| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cytoskeletal protein binding | KIF13B MYH7 DPYSL3 HIP1 SPAST MYH7B SYNE1 SPTAN1 CD2AP OBSCN FHOD3 EPB41L3 GOLGA8N LRP8 TUBGCP6 SPTBN4 CCDC88A MACF1 BEX4 TNNC2 LIMCH1 PLEC MYO18B GOLGA8O IQGAP3 EPB41 NIN | 3.94e-07 | 1099 | 166 | 27 | GO:0008092 |
| GeneOntologyMolecularFunction | actin filament binding | MYH7 HIP1 MYH7B SYNE1 SPTAN1 CD2AP FHOD3 SPTBN4 MACF1 PLEC MYO18B IQGAP3 | 4.55e-07 | 227 | 166 | 12 | GO:0051015 |
| GeneOntologyMolecularFunction | actin binding | MYH7 HIP1 MYH7B SYNE1 SPTAN1 CD2AP FHOD3 EPB41L3 SPTBN4 CCDC88A MACF1 TNNC2 LIMCH1 PLEC MYO18B IQGAP3 EPB41 | 5.41e-07 | 479 | 166 | 17 | GO:0003779 |
| GeneOntologyMolecularFunction | structural constituent of cytoskeleton | 1.32e-05 | 130 | 166 | 8 | GO:0005200 | |
| GeneOntologyMolecularFunction | microtubule minus-end binding | 2.39e-04 | 15 | 166 | 3 | GO:0051011 | |
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 2.46e-04 | 37 | 166 | 4 | GO:0140658 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | KIF13B MYH7 SPAST SRCAP MORC2 DDX50 DQX1 SMARCA4 ACIN1 MACF1 CHD6 RAD54L | 3.30e-04 | 441 | 166 | 12 | GO:0016887 |
| GeneOntologyMolecularFunction | cytoskeletal protein-membrane anchor activity | 4.08e-04 | 4 | 166 | 2 | GO:0106006 | |
| GeneOntologyMolecularFunction | structural molecule activity | COL9A2 HIP1 COPG1 SPTAN1 CD2AP OBSCN LAMB2 EPB41L3 ERBIN SPTBN4 JAG1 MRPS24 MMRN2 MACF1 ERVK-19 CRYBG3 PLEC EPB41 | 4.57e-04 | 891 | 166 | 18 | GO:0005198 |
| GeneOntologyMolecularFunction | ankyrin binding | 8.84e-04 | 23 | 166 | 3 | GO:0030506 | |
| GeneOntologyMolecularFunction | dihydropyrimidinase activity | 1.01e-03 | 6 | 166 | 2 | GO:0004157 | |
| GeneOntologyBiologicalProcess | actomyosin structure organization | MYH7 OBSCN FHOD3 EPB41L3 CCDC88A PIK3R2 LIMCH1 PLEC MYO18B IQGAP3 EPB41 | 3.69e-06 | 239 | 165 | 11 | GO:0031032 |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | CACNA1A KIF13B SPAST ZFYVE27 SYNE1 CD2AP LAMB2 SEMA3G EPB41L3 RUNX3 CIT GOLGA8N LRP8 SPTBN4 DOCK7 MACF1 TBR1 GOLGA8O NIN | 2.37e-05 | 802 | 165 | 19 | GO:0048812 |
| GeneOntologyBiologicalProcess | supramolecular fiber organization | MYH7 DPYSL3 HIP1 SPAST SPTAN1 CD2AP OBSCN FHOD3 SERPINH1 CIT GOLGA8N TUBGCP6 SPTBN4 FAT1 CCDC88A PIK3R2 LIMCH1 PLEC GOLGA8O IQGAP3 NIN | 2.68e-05 | 957 | 165 | 21 | GO:0097435 |
| GeneOntologyBiologicalProcess | cell morphogenesis | CACNA1A KIF13B SPAST ZFYVE27 SYNE1 CD2AP LAMB2 SEMA3G EPB41L3 RUNX3 CIT GOLGA8N LRP8 SPTBN4 FAT1 NBEAL2 DOCK7 SMARCA4 MACF1 PLEC TBR1 GOLGA8O EPB41 NIN | 2.85e-05 | 1194 | 165 | 24 | GO:0000902 |
| GeneOntologyBiologicalProcess | cortical actin cytoskeleton organization | 2.91e-05 | 45 | 165 | 5 | GO:0030866 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | CACNA1A KIF13B SPAST ZFYVE27 SYNE1 CD2AP LAMB2 SEMA3G EPB41L3 RUNX3 CIT GOLGA8N LRP8 SPTBN4 DOCK7 MACF1 TBR1 GOLGA8O NIN | 3.16e-05 | 819 | 165 | 19 | GO:0120039 |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | CACNA1A KIF13B SPAST ZFYVE27 SYNE1 CD2AP LAMB2 SEMA3G RUNX3 CIT GOLGA8N LRP8 SPTBN4 DOCK7 MACF1 TBR1 GOLGA8O NIN | 3.21e-05 | 748 | 165 | 18 | GO:0048667 |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | CACNA1A KIF13B SPAST ZFYVE27 SYNE1 CD2AP LAMB2 SEMA3G EPB41L3 RUNX3 CIT GOLGA8N LRP8 SPTBN4 DOCK7 MACF1 TBR1 GOLGA8O NIN | 3.54e-05 | 826 | 165 | 19 | GO:0048858 |
| GeneOntologyBiologicalProcess | axonogenesis | CACNA1A KIF13B SPAST ZFYVE27 CD2AP LAMB2 SEMA3G RUNX3 GOLGA8N SPTBN4 DOCK7 MACF1 TBR1 GOLGA8O NIN | 5.17e-05 | 566 | 165 | 15 | GO:0007409 |
| GeneOntologyBiologicalProcess | axon development | CACNA1A KIF13B SPAST ZFYVE27 CD2AP LAMB2 SEMA3G EPB41L3 RUNX3 GOLGA8N SPTBN4 DOCK7 MACF1 TBR1 GOLGA8O NIN | 5.99e-05 | 642 | 165 | 16 | GO:0061564 |
| GeneOntologyBiologicalProcess | actin cytoskeleton organization | MYH7 DPYSL3 HIP1 SPTAN1 CD2AP OBSCN FHOD3 EPB41L3 CIT SPTBN4 FAT1 CCDC88A PIK3R2 LIMCH1 PLEC MYO18B IQGAP3 EPB41 | 8.00e-05 | 803 | 165 | 18 | GO:0030036 |
| GeneOntologyBiologicalProcess | cortical cytoskeleton organization | 9.23e-05 | 57 | 165 | 5 | GO:0030865 | |
| GeneOntologyBiologicalProcess | regulation of neuron projection development | CACNA1A KIF13B DPYSL2 DPYSL3 ZFYVE27 SYNE1 SEMA3G CIT GOLGA8N LRP8 CCDC88A MACF1 TBR1 GOLGA8O NIN | 1.23e-04 | 612 | 165 | 15 | GO:0010975 |
| GeneOntologyBiologicalProcess | actin filament-based process | MYH7 DPYSL3 HIP1 MYH7B SPTAN1 CD2AP OBSCN FHOD3 EPB41L3 CIT SPTBN4 FAT1 CCDC88A PIK3R2 LIMCH1 PLEC MYO18B IQGAP3 EPB41 | 1.31e-04 | 912 | 165 | 19 | GO:0030029 |
| GeneOntologyBiologicalProcess | regulation of axonogenesis | 1.61e-04 | 192 | 165 | 8 | GO:0050770 | |
| GeneOntologyBiologicalProcess | actin filament organization | DPYSL3 HIP1 SPTAN1 CD2AP FHOD3 CIT SPTBN4 FAT1 CCDC88A PIK3R2 LIMCH1 PLEC IQGAP3 | 2.37e-04 | 509 | 165 | 13 | GO:0007015 |
| GeneOntologyCellularComponent | myofibril | MYH7 MYH7B SYNE1 SPTAN1 PSMA6 OBSCN STYXL2 FHOD3 RTL1 TNNC2 PLEC MYO18B | 2.24e-06 | 273 | 168 | 12 | GO:0030016 |
| GeneOntologyCellularComponent | supramolecular fiber | KIF13B DPYSL2 MYH7 DPYSL3 RPGRIP1L SPAST MYH7B SYNE1 SPTAN1 CD2AP PSMA6 OBSCN STYXL2 FHOD3 GOLGA8N TUBGCP6 SPTBN4 RTL1 MACF1 BEX4 TNNC2 PLEC MYO18B GOLGA8O CEP170B NIN | 2.68e-06 | 1179 | 168 | 26 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | KIF13B DPYSL2 MYH7 DPYSL3 RPGRIP1L SPAST MYH7B SYNE1 SPTAN1 CD2AP PSMA6 OBSCN STYXL2 FHOD3 GOLGA8N TUBGCP6 SPTBN4 RTL1 MACF1 BEX4 TNNC2 PLEC MYO18B GOLGA8O CEP170B NIN | 3.03e-06 | 1187 | 168 | 26 | GO:0099081 |
| GeneOntologyCellularComponent | contractile muscle fiber | MYH7 MYH7B SYNE1 SPTAN1 PSMA6 OBSCN STYXL2 FHOD3 RTL1 TNNC2 PLEC MYO18B | 4.18e-06 | 290 | 168 | 12 | GO:0043292 |
| GeneOntologyCellularComponent | sarcomere | MYH7 SYNE1 SPTAN1 PSMA6 OBSCN STYXL2 FHOD3 RTL1 TNNC2 PLEC MYO18B | 5.73e-06 | 249 | 168 | 11 | GO:0030017 |
| GeneOntologyCellularComponent | Golgi cis cisterna | 6.25e-06 | 33 | 168 | 5 | GO:0000137 | |
| GeneOntologyCellularComponent | paranode region of axon | 8.83e-06 | 17 | 168 | 4 | GO:0033270 | |
| GeneOntologyCellularComponent | myosin filament | 4.46e-05 | 25 | 168 | 4 | GO:0032982 | |
| GeneOntologyCellularComponent | myosin II complex | 7.09e-05 | 28 | 168 | 4 | GO:0016460 | |
| GeneOntologyCellularComponent | Golgi cisterna | 1.12e-04 | 135 | 168 | 7 | GO:0031985 | |
| GeneOntologyCellularComponent | Z disc | 2.24e-04 | 151 | 168 | 7 | GO:0030018 | |
| GeneOntologyCellularComponent | actin cytoskeleton | MYH7 DPYSL3 HIP1 MYH7B SPTAN1 CD2AP FHOD3 CIT SPTBN4 MACF1 TNNC2 LIMCH1 MYO18B EPB41 | 2.39e-04 | 576 | 168 | 14 | GO:0015629 |
| GeneOntologyCellularComponent | I band | 3.97e-04 | 166 | 168 | 7 | GO:0031674 | |
| GeneOntologyCellularComponent | Golgi stack | 4.75e-04 | 171 | 168 | 7 | GO:0005795 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | SYNE1 SNRNP35 KDM3B GON4L GEMIN5 SRCAP RUNX3 HNRNPF HNRNPH1 FANCC ORC2 NCOR2 R3HCC1L DQX1 TAF7L DOCK7 CTNNBL1 SMARCA4 ACIN1 COPS6 MGA LSM10 RBM41 | 6.78e-04 | 1377 | 168 | 23 | GO:0140513 |
| GeneOntologyCellularComponent | Golgi cisterna membrane | 9.74e-04 | 94 | 168 | 5 | GO:0032580 | |
| GeneOntologyCellularComponent | myosin complex | 1.30e-03 | 59 | 168 | 4 | GO:0016459 | |
| GeneOntologyCellularComponent | endoplasmic reticulum tubular network | 1.94e-03 | 31 | 168 | 3 | GO:0071782 | |
| GeneOntologyCellularComponent | myofilament | 2.13e-03 | 32 | 168 | 3 | GO:0036379 | |
| GeneOntologyCellularComponent | spectrin | 2.23e-03 | 9 | 168 | 2 | GO:0008091 | |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | KIF13B DPYSL2 DPYSL3 RPGRIP1L SPAST CD2AP GOLGA8N TUBGCP6 SPTBN4 MACF1 BEX4 PLEC MYO18B GOLGA8O CEP170B NIN | 2.47e-03 | 899 | 168 | 16 | GO:0099513 |
| GeneOntologyCellularComponent | nuclear body | CENPT ZC3H13 OBSCN GON4L GEMIN5 E4F1 SRCAP PHAX ERBIN SPTBN4 NCOR2 SCAPER ACIN1 LSM10 SMURF2 EPB41 | 2.58e-03 | 903 | 168 | 16 | GO:0016604 |
| Domain | Znf_CHHC | 6.05e-07 | 3 | 159 | 3 | IPR012996 | |
| Domain | zf-RNPHF | 6.05e-07 | 3 | 159 | 3 | PF08080 | |
| Domain | Spectrin_repeat | 4.23e-06 | 29 | 159 | 5 | IPR002017 | |
| Domain | SPEC | 7.02e-06 | 32 | 159 | 5 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 7.02e-06 | 32 | 159 | 5 | IPR018159 | |
| Domain | CH | 1.89e-05 | 65 | 159 | 6 | SM00033 | |
| Domain | CH | 2.90e-05 | 70 | 159 | 6 | PF00307 | |
| Domain | - | 3.14e-05 | 71 | 159 | 6 | 1.10.418.10 | |
| Domain | CH | 3.68e-05 | 73 | 159 | 6 | PS50021 | |
| Domain | Spectrin | 3.95e-05 | 23 | 159 | 4 | PF00435 | |
| Domain | ACTININ_2 | 3.95e-05 | 23 | 159 | 4 | PS00020 | |
| Domain | ACTININ_1 | 3.95e-05 | 23 | 159 | 4 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 3.95e-05 | 23 | 159 | 4 | IPR001589 | |
| Domain | CH-domain | 4.29e-05 | 75 | 159 | 6 | IPR001715 | |
| Domain | T-box_assoc | 7.20e-05 | 2 | 159 | 2 | PF16176 | |
| Domain | T-box_assoc | 7.20e-05 | 2 | 159 | 2 | IPR032385 | |
| Domain | Jagged/Serrate | 7.20e-05 | 2 | 159 | 2 | IPR026219 | |
| Domain | SNF2_N | 1.51e-04 | 32 | 159 | 4 | IPR000330 | |
| Domain | SNF2_N | 1.51e-04 | 32 | 159 | 4 | PF00176 | |
| Domain | Helicase_C | 3.24e-04 | 108 | 159 | 6 | IPR001650 | |
| Domain | HELICASE_CTER | 3.41e-04 | 109 | 159 | 6 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 3.41e-04 | 109 | 159 | 6 | PS51192 | |
| Domain | DEXDc | 3.41e-04 | 109 | 159 | 6 | SM00487 | |
| Domain | Helicase_ATP-bd | 3.58e-04 | 110 | 159 | 6 | IPR014001 | |
| Domain | TF_T-box | 3.77e-04 | 17 | 159 | 3 | IPR001699 | |
| Domain | TBOX | 3.77e-04 | 17 | 159 | 3 | SM00425 | |
| Domain | TF_T-box_CS | 3.77e-04 | 17 | 159 | 3 | IPR018186 | |
| Domain | - | 3.77e-04 | 17 | 159 | 3 | 2.60.40.820 | |
| Domain | TBOX_3 | 3.77e-04 | 17 | 159 | 3 | PS50252 | |
| Domain | T-box | 3.77e-04 | 17 | 159 | 3 | PF00907 | |
| Domain | TBOX_1 | 3.77e-04 | 17 | 159 | 3 | PS01283 | |
| Domain | TBOX_2 | 3.77e-04 | 17 | 159 | 3 | PS01264 | |
| Domain | HSA | 4.27e-04 | 4 | 159 | 2 | SM00573 | |
| Domain | 4_1_CTD | 4.27e-04 | 4 | 159 | 2 | PF05902 | |
| Domain | HSA | 4.27e-04 | 4 | 159 | 2 | PS51204 | |
| Domain | SAB | 4.27e-04 | 4 | 159 | 2 | PF04382 | |
| Domain | Band_4.1_C | 4.27e-04 | 4 | 159 | 2 | IPR008379 | |
| Domain | DSL | 4.27e-04 | 4 | 159 | 2 | PF01414 | |
| Domain | SAB_dom | 4.27e-04 | 4 | 159 | 2 | IPR007477 | |
| Domain | HSA_dom | 4.27e-04 | 4 | 159 | 2 | IPR014012 | |
| Domain | HSA | 4.27e-04 | 4 | 159 | 2 | PF07529 | |
| Domain | DSL | 4.27e-04 | 4 | 159 | 2 | SM00051 | |
| Domain | GOLGA2L5 | 4.50e-04 | 18 | 159 | 3 | PF15070 | |
| Domain | Golgin_A | 4.50e-04 | 18 | 159 | 3 | IPR024858 | |
| Domain | Myosin-like_IQ_dom | 5.31e-04 | 19 | 159 | 3 | IPR027401 | |
| Domain | - | 5.31e-04 | 19 | 159 | 3 | 4.10.270.10 | |
| Domain | IQ | 6.39e-04 | 81 | 159 | 5 | SM00015 | |
| Domain | DSL | 7.08e-04 | 5 | 159 | 2 | PS51051 | |
| Domain | Notch_ligand_N | 7.08e-04 | 5 | 159 | 2 | IPR011651 | |
| Domain | MNNL | 7.08e-04 | 5 | 159 | 2 | PF07657 | |
| Domain | DSL | 7.08e-04 | 5 | 159 | 2 | IPR001774 | |
| Domain | EF_HAND_2 | 8.30e-04 | 231 | 159 | 8 | PS50222 | |
| Domain | EF_hand_dom | 8.54e-04 | 232 | 159 | 8 | IPR002048 | |
| Domain | IQ_motif_EF-hand-BS | 1.03e-03 | 90 | 159 | 5 | IPR000048 | |
| Domain | BRK | 1.06e-03 | 6 | 159 | 2 | SM00592 | |
| Domain | - | 1.06e-03 | 6 | 159 | 2 | 3.90.1290.10 | |
| Domain | BRK_domain | 1.06e-03 | 6 | 159 | 2 | IPR006576 | |
| Domain | Hydantoinase/dihydroPyrase | 1.06e-03 | 6 | 159 | 2 | IPR011778 | |
| Domain | BRK | 1.06e-03 | 6 | 159 | 2 | PF07533 | |
| Domain | p53-like_TF_DNA-bd | 1.07e-03 | 53 | 159 | 4 | IPR008967 | |
| Domain | IQ | 1.19e-03 | 93 | 159 | 5 | PS50096 | |
| Domain | Plectin | 1.47e-03 | 7 | 159 | 2 | PF00681 | |
| Domain | Plectin_repeat | 1.47e-03 | 7 | 159 | 2 | IPR001101 | |
| Domain | PLEC | 1.47e-03 | 7 | 159 | 2 | SM00250 | |
| Domain | Nucleotide-bd_a/b_plait | 1.68e-03 | 258 | 159 | 8 | IPR012677 | |
| Domain | - | 1.81e-03 | 261 | 159 | 8 | 1.10.238.10 | |
| Domain | EF_HAND_1 | 1.84e-03 | 204 | 159 | 7 | PS00018 | |
| Domain | - | 1.95e-03 | 8 | 159 | 2 | 2.30.40.10 | |
| Domain | Helicase_C | 2.22e-03 | 107 | 159 | 5 | PF00271 | |
| Domain | HELICc | 2.22e-03 | 107 | 159 | 5 | SM00490 | |
| Domain | ARM-like | 2.23e-03 | 270 | 159 | 8 | IPR011989 | |
| Domain | DUF4939 | 3.10e-03 | 10 | 159 | 2 | IPR032549 | |
| Domain | Amidohydro_1 | 3.10e-03 | 10 | 159 | 2 | PF01979 | |
| Domain | Metal-dep_hydrolase_composite | 3.10e-03 | 10 | 159 | 2 | IPR011059 | |
| Domain | DUF4939 | 3.10e-03 | 10 | 159 | 2 | PF16297 | |
| Domain | EF-hand-dom_pair | 3.24e-03 | 287 | 159 | 8 | IPR011992 | |
| Pubmed | DPYSL2 DPYSL3 SPTAN1 CD2AP KDM3B GEMIN5 SRCAP PHAX DNAJC7 ERBIN NUDT5 RABEP1 XRN1 DOCK7 SMARCA4 ACIN1 PC MGA GCN1 EPB41 | 3.42e-12 | 549 | 169 | 20 | 38280479 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | DPYSL2 DPYSL3 PSMA6 KDM3B GEMIN5 PFAS SRCAP PHAX EPB41L3 ERBIN GFPT1 HNRNPF HNRNPH1 ORC2 R3HCC1L NUDT5 DDX50 RABEP1 XRN1 SMARCA4 ACIN1 MACF1 PC GCN1 EPB41 | 4.93e-12 | 934 | 169 | 25 | 33916271 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | DPYSL2 COPG1 SPTAN1 PSMA6 GEMIN5 PFAS SRCAP EPB41L3 SERPINH1 ERBIN GFPT1 HNRNPF HNRNPH1 HNRNPH2 NCOR2 EEF1D IPO9 DDX50 XRN1 CTNNBL1 SMARCA4 PYCR1 ACIN1 MACF1 UTP20 PLEC MGA GCN1 CCDC93 | 1.82e-11 | 1353 | 169 | 29 | 29467282 |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | DPYSL2 DPYSL3 COPG1 PEG10 SPTAN1 CD2AP PSMA6 NUCB1 KDM3B LAMB2 GEMIN5 PFAS PHAX DNAJC7 SERPINH1 GFPT1 HNRNPF HNRNPH1 EEF1D FARSA TRNT1 IPO9 NUDT5 RABEP1 MACF1 LIMCH1 PLEC COPS6 GCN1 | 1.01e-10 | 1455 | 169 | 29 | 22863883 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | KIF13B DPYSL3 SPAST PARP8 SPTAN1 CD2AP KDM3B EPB41L3 SERPINH1 ERBIN CCDC88A IPO9 RABEP1 XRN1 DOCK7 MACF1 LIMCH1 CRYBG3 PLEC PC CEP170B EPB41 | 2.51e-10 | 861 | 169 | 22 | 36931259 |
| Pubmed | DPYSL2 SPAST PEG10 SPTAN1 CD2AP SERPINH1 HNRNPF HNRNPH1 DARS2 RABEP1 MMRN2 ACIN1 MACF1 PLEC PC | 3.14e-10 | 360 | 169 | 15 | 33111431 | |
| Pubmed | KIF13B MYH7 MYH7B SYNE1 PARP8 SPTAN1 PSMA6 NUCB1 ASH1L SRCAP EPB41L3 DNAJC7 ERBIN HNRNPF SPTBN4 EEF1D TRNT1 DDX50 XRN1 PYCR1 ACIN1 MACF1 ATG4C CHD6 LIMCH1 PLEC SMURF2 UTP14C | 4.01e-10 | 1442 | 169 | 28 | 35575683 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | DPYSL2 HIP1 COPG1 ERAP1 CD2AP PSMA6 KDM3B GEMIN5 PFAS EPB41L3 DNAJC7 SERPINH1 ERBIN GFPT1 HNRNPF HNRNPH2 NCOR2 EEF1D IPO9 NUDT5 CTNNBL1 PYCR1 ACIN1 PC COPS6 GCN1 EPB41 | 5.93e-10 | 1367 | 169 | 27 | 32687490 |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | DPYSL2 ZFYVE27 COPG1 ZC3H13 OBSCN ACVR1B GFPT1 HNRNPF HNRNPH1 DARS2 FAM20C R3HCC1L DQX1 EXOC3L4 ARID5B CTNNBL1 UTP20 CHD6 TBR1 RBM41 | 6.08e-10 | 736 | 169 | 20 | 29676528 |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | KIF13B RPGRIP1L PFAS SRCAP DNAJC7 SERPINH1 NCOR2 FARSA CCDC88A NUDT5 NFATC2IP RABEP1 ARID5B MACF1 CRYBG3 CEP170B CDCA4 NIN | 7.17e-10 | 588 | 169 | 18 | 38580884 |
| Pubmed | DPYSL2 SPAST PEG10 SYNE1 SPTAN1 TMEM59 NUCB1 ASH1L DNAJC7 CIT CBR3 GFPT1 HNRNPF SPTBN4 RABEP1 USP32 ARID5B SMARCA4 MACF1 BEX4 CHD6 RAB11FIP4 PLEC PC SMURF2 DKK3 | 7.74e-10 | 1285 | 169 | 26 | 35914814 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | COPG1 SYNE1 SPTAN1 PSMA6 GEMIN5 PFAS EPB41L3 DNAJC7 SERPINH1 GFPT1 HNRNPF HNRNPH1 DARS2 EEF1D FARSA IPO9 DDX50 DOCK7 CTNNBL1 SMARCA4 PYCR1 ACIN1 UTP20 MYO18B PC GCN1 IQGAP3 | 1.45e-09 | 1425 | 169 | 27 | 30948266 |
| Pubmed | CACNA1A DPYSL2 TUT4 SPAST COPG1 TSPOAP1 SPTAN1 EPB41L3 CIT ERBIN HNRNPH2 EEF1D CCDC88A RABEP1 XRN1 DOCK7 MACF1 CRYBG3 PLEC PC GCN1 CEP170B EPB41 WNK2 | 1.69e-09 | 1139 | 169 | 24 | 36417873 | |
| Pubmed | CACNA1A KIF13B DPYSL2 SYNE1 SPTAN1 EPB41L3 CIT ERBIN GOLGA8N SPTBN4 NCOR2 FARSA CCDC88A RABEP1 DOCK7 SMARCA4 MACF1 LIMCH1 GOLGA8O MGA CEP170B WNK2 | 1.99e-09 | 963 | 169 | 22 | 28671696 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | DPYSL2 MYH7 DPYSL3 COPG1 SPTAN1 CD2AP PSMA6 GEMIN5 PFAS DNAJC7 SERPINH1 HNRNPF HNRNPH1 EEF1D IPO9 NUDT5 DOCK7 PYCR1 MACF1 LIMCH1 PLEC COPS6 GCN1 IQGAP3 | 2.01e-09 | 1149 | 169 | 24 | 35446349 |
| Pubmed | CD2AP GEMIN5 EPB41L3 NCOR2 CCDC88A RABEP1 ARID5B XRN1 DOCK7 CHD6 CRYBG3 PLEC PC MGA GCN1 | 2.42e-09 | 418 | 169 | 15 | 34709266 | |
| Pubmed | DPYSL3 CENPT SPTAN1 CD2AP GON4L SRCAP MORC2 EPB41L3 SERPINH1 ERBIN IPO9 NUDT5 NFATC2IP XRN1 DOCK7 CHD6 EPB41 NIN | 3.06e-09 | 645 | 169 | 18 | 25281560 | |
| Pubmed | DPYSL2 COPG1 ZC3H13 SPTAN1 GEMIN5 PFAS EPB41L3 SERPINH1 GFPT1 HNRNPF XRN1 DOCK7 SMARCA4 ACIN1 MACF1 UTP20 PLEC GCN1 | 3.71e-09 | 653 | 169 | 18 | 22586326 | |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | GEMIN5 CIT HNRNPF XRN1 DOCK7 CRYBG1 UTP20 PLEC TBR1 GCN1 IQGAP3 | 5.01e-09 | 202 | 169 | 11 | 33005030 |
| Pubmed | MYH7 DPYSL3 TUT4 COPG1 SYNE1 SPTAN1 PSMA6 PFAS MORC2 DNAJC7 HNRNPH1 NCOR2 EEF1D CTNNBL1 SMARCA4 PYCR1 CHD6 LIMCH1 MGA | 5.72e-09 | 754 | 169 | 19 | 35906200 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | COPG1 ZC3H13 PSMA6 KDM3B GEMIN5 SERPINH1 HNRNPF HNRNPH1 HNRNPH2 DARS2 ORC2 EEF1D FARSA TRNT1 IPO9 DDX50 CTNNBL1 SMARCA4 PYCR1 ACIN1 CRYBG1 CHD6 PLEC PC GCN1 | 6.20e-09 | 1318 | 169 | 25 | 30463901 |
| Pubmed | CACNA1A DPYSL2 DPYSL3 SYNE1 SPTAN1 PSMA6 GEMIN5 EPB41L3 CIT ERBIN HNRNPF HNRNPH1 CADM2 SPTBN4 EEF1D FARSA SCAPER XRN1 DOCK7 SMARCA4 MACF1 LIMCH1 PLEC PC CEP170B WNK2 | 7.18e-09 | 1431 | 169 | 26 | 37142655 | |
| Pubmed | COL9A2 SPAST ERAP1 CD2AP ASH1L LAMB2 PFAS DNAJC7 HNRNPH1 EEF1D FAT1 IPO9 CROCC2 EXOC3L4 SCAPER TBR1 MGA THAP12 | 8.50e-09 | 689 | 169 | 18 | 36543142 | |
| Pubmed | DPYSL2 PSMA6 GEMIN5 PFAS DNAJC7 GFPT1 HNRNPH1 HNRNPH2 DARS2 FARSA IPO9 XRN1 DOCK7 PYCR1 GCN1 EPB41 | 8.98e-09 | 534 | 169 | 16 | 35032548 | |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | KIF13B COPG1 PFAS MORC2 GFPT1 HNRNPF HNRNPH1 HNRNPH2 DARS2 EEF1D FARSA MRPS24 CTNNBL1 SMARCA4 UTP20 PC GCN1 IQGAP3 | 1.18e-08 | 704 | 169 | 18 | 29955894 |
| Pubmed | Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways. | DPYSL2 RPGRIP1L SPTAN1 PSMA6 NUCB1 OBSCN SERPINH1 HNRNPF HNRNPH1 HNRNPH2 IPO9 RABEP1 EXOC3L4 PLEC GCN1 IQGAP3 | 1.92e-08 | 564 | 169 | 16 | 21565611 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | HIP1 OBSCN KDM3B LAMB2 GEMIN5 PFAS SRCAP ZNF236 CIT JAG2 NCOR2 FAM20C FAT1 NBEAL2 PLEC PC LSM10 GCN1 SMURF2 IQGAP3 CEP170B WNK2 | 2.36e-08 | 1105 | 169 | 22 | 35748872 |
| Pubmed | USP45 and Spindly are part of the same complex implicated in cell migration. | DPYSL2 DPYSL3 TUT4 COPG1 SPTAN1 LAMB2 HNRNPH1 EEF1D PLEC TBR1 WNK2 | 2.40e-08 | 235 | 169 | 11 | 30258100 |
| Pubmed | HIP1 COPG1 CD2AP EPB41L3 ERBIN HNRNPF HNRNPH1 FARSA IPO9 RABEP1 XRN1 DOCK7 GCN1 EPB41 | 4.85e-08 | 449 | 169 | 14 | 31732153 | |
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | SPTAN1 CD2AP GEMIN5 EEF1D CCDC88A XRN1 LIMCH1 PLEC GOLGA8O GCN1 EPB41 | 5.75e-08 | 256 | 169 | 11 | 33397691 |
| Pubmed | DPYSL2 DPYSL3 SYNE1 SPTAN1 DNAJC7 NCOR2 CCDC88A MACF1 CCDC93 | 5.96e-08 | 151 | 169 | 9 | 17043677 | |
| Pubmed | CD2AP PSMA6 EPB41L3 DNAJC7 ERBIN GFPT1 HNRNPF HNRNPH1 FARSA CCDC88A NUDT5 XRN1 DOCK7 MACF1 CRYBG3 GCN1 EPB41 | 7.58e-08 | 708 | 169 | 17 | 39231216 | |
| Pubmed | 7.89e-08 | 156 | 169 | 9 | 32850835 | ||
| Pubmed | 1.13e-07 | 3 | 169 | 3 | 14980514 | ||
| Pubmed | 1.13e-07 | 3 | 169 | 3 | 7499401 | ||
| Pubmed | 1.13e-07 | 3 | 169 | 3 | 10456323 | ||
| Pubmed | SYNE1 SPTAN1 LAMB2 EPB41L3 DNAJC7 ERBIN CCDC88A PIK3R2 MACF1 CHD6 PLEC MGA GCN1 WNK2 | 1.28e-07 | 486 | 169 | 14 | 20936779 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | SYNE1 TMEM59 LAMB2 SRCAP DNAJC7 SERPINH1 CIT HNRNPF HNRNPH1 HNRNPH2 EEF1D DDX50 DOCK7 SMARCA4 ACIN1 MACF1 UTP20 PLEC MGA GCN1 | 1.46e-07 | 1024 | 169 | 20 | 24711643 |
| Pubmed | SPAST SRCAP MORC2 CIT EEF1D SCAPER XRN1 CTNNBL1 MACF1 PC RAD54L | 1.47e-07 | 281 | 169 | 11 | 24163370 | |
| Pubmed | MYH7 PEG10 SYNE1 OBSCN GON4L ZNF407 PHAX PRKD3 RABEP1 MACF1 PLEC MYO18B COPS6 MGA | 1.68e-07 | 497 | 169 | 14 | 23414517 | |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | DPYSL2 DPYSL3 ZC3H13 SPTAN1 PSMA6 GEMIN5 SRCAP DNAJC7 CIT HNRNPH1 EEF1D IPO9 NUDT5 SCAPER SMARCA4 MACF1 PLEC CCDC93 | 1.89e-07 | 847 | 169 | 18 | 35235311 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | CYP4V2 DPYSL2 TUT4 CD2AP ASH1L OBSCN ZNF236 ERBIN HNRNPF LRP8 JAG2 SPTBN4 NCOR2 TRNT1 TMEM98 RABEP1 ARID5B MACF1 CHD6 LIMCH1 SMURF2 CEP170B EPB41 WNK2 | 2.64e-07 | 1489 | 169 | 24 | 28611215 |
| Pubmed | ERAP1 NUCB1 GEMIN5 DNAJC7 CIT HNRNPF HNRNPH1 HNRNPH2 LRP8 TUBGCP6 ORC2 NCOR2 FARSA IPO9 DDX50 NBEAL2 XRN1 CTNNBL1 SMARCA4 ARHGAP45 GCN1 | 2.74e-07 | 1168 | 169 | 21 | 19946888 | |
| Pubmed | RPGRIP1L ZFYVE27 COPG1 KDM3B ACVR1B EPB41L3 ERBIN TRIM23 FAT1 CCDC88A DDX50 XRN1 DOCK7 PC MGA GCN1 EPB41 | 2.81e-07 | 777 | 169 | 17 | 35844135 | |
| Pubmed | COPG1 SERPINH1 GFPT1 HNRNPF HNRNPH2 EEF1D IPO9 DOCK7 SMARCA4 PYCR1 MACF1 PLEC PC GCN1 CEP170B | 2.82e-07 | 601 | 169 | 15 | 33658012 | |
| Pubmed | HIP1 SYNE1 CD2AP GON4L LAMB2 GEMIN5 E4F1 MORC2 SERPINH1 CIT ERBIN FARSA DDX50 XRN1 CTNNBL1 CRYBG1 MACF1 UTP20 CHD6 LIMCH1 THAP12 IQGAP3 CEP170B EPB41 | 2.90e-07 | 1497 | 169 | 24 | 31527615 | |
| Pubmed | KIF13B ZC3H13 CD2AP ASH1L OBSCN GEMIN5 SRCAP ERBIN HNRNPF TRNT1 DDX50 TMEM98 EXOC3L4 ARID5B ACIN1 CRYBG1 MACF1 PLEC MGA UTP14C | 3.60e-07 | 1084 | 169 | 20 | 11544199 | |
| Pubmed | Jagged1 is Essential for Radial Glial Maintenance in the Cortical Proliferative Zone. | 3.72e-07 | 13 | 169 | 4 | 31202705 | |
| Pubmed | 3.72e-07 | 13 | 169 | 4 | 34838591 | ||
| Pubmed | PROTAC-mediated degradation reveals a non-catalytic function of AURORA-A kinase. | COPG1 PSMA6 GOLGA8R HNRNPH2 PIK3R2 DOCK7 SMARCA4 ACIN1 ARHGAP45 NIN | 4.05e-07 | 247 | 169 | 10 | 32989298 |
| Pubmed | 4.62e-07 | 32 | 169 | 5 | 23704327 | ||
| Pubmed | 4.85e-07 | 60 | 169 | 6 | 20682791 | ||
| Pubmed | alphaII-Spectrin interacts with five groups of functionally important proteins in the nucleus. | 6.34e-07 | 34 | 169 | 5 | 16889989 | |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | COPG1 SPTAN1 GEMIN5 SRCAP HNRNPH2 NFATC2IP CTNNBL1 SMARCA4 ACIN1 PLEC GCN1 | 7.69e-07 | 332 | 169 | 11 | 32786267 |
| Pubmed | Quantitative analysis of PPT1 interactome in human neuroblastoma cells. | 9.74e-07 | 210 | 169 | 9 | 26217791 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | DPYSL2 DPYSL3 RPGRIP1L CD2AP DNAJC7 GFPT1 HNRNPH1 HNRNPH2 CCDC88A NUDT5 XRN1 PLEC PC MGA CEP170B EPB41 NIN | 1.02e-06 | 853 | 169 | 17 | 28718761 |
| Pubmed | LAMB2 FHOD3 EPB41L3 GFPT1 DDX50 NDUFAF7 CROCC2 FER1L4 MRPS24 ARID5B MACF1 PLEC MYO18B | 1.05e-06 | 496 | 169 | 13 | 31343991 | |
| Pubmed | FBXO32 links ubiquitination to epigenetic reprograming of melanoma cells. | 1.05e-06 | 212 | 169 | 9 | 33462405 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | COPG1 SPTAN1 EPB41L3 HNRNPF HNRNPH1 ORC2 NCOR2 IPO9 SMARCA4 ACIN1 MACF1 PLEC COPS6 GCN1 | 1.10e-06 | 582 | 169 | 14 | 20467437 |
| Pubmed | The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation. | MORC2 EPB41L3 RUNX3 DNAJC7 HNRNPF HNRNPH1 HNRNPH2 ORC2 FARSA DDX50 SMARCA4 ACIN1 MGA EPB41 | 1.12e-06 | 583 | 169 | 14 | 29844126 |
| Pubmed | 1.43e-06 | 220 | 169 | 9 | 24550385 | ||
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | DPYSL2 SYNE1 ZC3H13 SPTAN1 SRCAP EPB41L3 HNRNPF HNRNPH1 HNRNPH2 FARSA DDX50 DOCK7 CTNNBL1 SMARCA4 ACIN1 MACF1 CHD6 PLEC GCN1 | 1.50e-06 | 1082 | 169 | 19 | 38697112 |
| Pubmed | SARS-CoV-2 uses Spike glycoprotein to control the host's anaerobic metabolism by inhibiting LDHB. | COPG1 SPTAN1 NUCB1 GRB7 GEMIN5 PFAS SERPINH1 GFPT1 DARS2 FARSA PYCR1 ACIN1 PC GCN1 | 1.80e-06 | 607 | 169 | 14 | 39147351 |
| Pubmed | 1.89e-06 | 118 | 169 | 7 | 30979931 | ||
| Pubmed | 2.16e-06 | 172 | 169 | 8 | 23184937 | ||
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | COPG1 SYNE1 SPTAN1 PSMA6 ASH1L SRCAP SERPINH1 GFPT1 HNRNPF HNRNPH1 EEF1D MACF1 PLEC PC GCN1 IQGAP3 | 2.29e-06 | 807 | 169 | 16 | 30575818 |
| Pubmed | TUT4 ASH1L SRCAP EPB41L3 TUBGCP6 NCOR2 FAT1 PIK3R2 TAF7L SCAPER XRN1 CTNNBL1 CRNN SMARCA4 MACF1 CRYBG3 MGA CEP170B NIN | 2.35e-06 | 1116 | 169 | 19 | 31753913 | |
| Pubmed | 2.38e-06 | 234 | 169 | 9 | 36243803 | ||
| Pubmed | Evolution of Cortical Neurogenesis in Amniotes Controlled by Robo Signaling Levels. | 2.45e-06 | 20 | 169 | 4 | 29961574 | |
| Pubmed | DPYSL2 PSMA6 KDM3B GEMIN5 PHAX MORC2 RUNX3 DNAJC7 SERPINH1 GFPT1 NCOR2 EEF1D FARSA TRNT1 CTNNBL1 SMARCA4 ACIN1 PLEC | 2.47e-06 | 1014 | 169 | 18 | 32416067 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | DPYSL2 TUT4 COPG1 SPTAN1 CD2AP GEMIN5 MORC2 EPB41L3 NUDT5 XRN1 DOCK7 MACF1 PLEC MGA GCN1 | 2.84e-06 | 724 | 169 | 15 | 36232890 |
| Pubmed | 3.02e-06 | 21 | 169 | 4 | 19686682 | ||
| Pubmed | 3.35e-06 | 244 | 169 | 9 | 28902428 | ||
| Pubmed | DPYSL3 RPGRIP1L SPTAN1 PFAS DNAJC7 ERBIN NCOR2 CCDC88A IPO9 NUDT5 DDX50 PYCR1 PDP2 CRYBG3 PC SLC12A7 GCN1 NIN | 3.95e-06 | 1049 | 169 | 18 | 27880917 | |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | COPG1 SYNE1 SPTAN1 LAMB2 SERPINH1 GFPT1 HNRNPF HNRNPH1 EEF1D DDX50 DOCK7 SMARCA4 UTP20 LIMCH1 PLEC PC EPB41 | 4.24e-06 | 949 | 169 | 17 | 36574265 |
| Pubmed | GEMIN5 GFPT1 HNRNPF HNRNPH1 NCOR2 EEF1D FARSA DDX50 ACIN1 UTP20 CHD6 PLEC PC GCN1 | 4.32e-06 | 655 | 169 | 14 | 35819319 | |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | SPTAN1 CD2AP EPB41L3 ERBIN EEF1D NUDT5 XRN1 CRYBG1 MACF1 LIMCH1 PLEC GCN1 EPB41 | 4.38e-06 | 565 | 169 | 13 | 25468996 |
| Pubmed | 4.43e-06 | 23 | 169 | 4 | 31504280 | ||
| Pubmed | DPYSL2 COPG1 SPTAN1 CD2AP EPB41L3 ORC2 EEF1D NUDT5 XRN1 LIMCH1 SLC12A7 GCN1 EPB41 | 4.63e-06 | 568 | 169 | 13 | 37774976 | |
| Pubmed | 4.69e-06 | 191 | 169 | 8 | 33762435 | ||
| Pubmed | Binding of USP4 to cortactin enhances cell migration in HCT116 human colon cancer cells. | 5.11e-06 | 137 | 169 | 7 | 37039823 | |
| Pubmed | TSPOAP1 SYNE1 GON4L ERBIN DOCK7 ACIN1 MACF1 CHD6 LIMCH1 RAB11FIP4 CEP170B | 5.45e-06 | 407 | 169 | 11 | 12693553 | |
| Pubmed | 6.28e-06 | 25 | 169 | 4 | 26143639 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | ZC3H13 SPTAN1 KDM3B GEMIN5 MORC2 ERBIN HNRNPF HNRNPH1 TUBGCP6 NCOR2 SMARCA4 ACIN1 UTP20 LIMCH1 PLEC | 6.33e-06 | 774 | 169 | 15 | 15302935 |
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | SPAST EPB41L3 GFPT1 HNRNPF HNRNPH2 DARS2 EEF1D XRN1 CTNNBL1 MACF1 GCN1 EPB41 | 6.50e-06 | 498 | 169 | 12 | 36634849 |
| Pubmed | PEG10 SPTAN1 PSMA6 GON4L SRCAP MORC2 DNAJC7 CIT ERBIN NCOR2 EEF1D FAT1 DDX50 MRPS24 ARID5B XRN1 SMARCA4 CHD6 TBR1 MGA FILIP1L | 6.60e-06 | 1429 | 169 | 21 | 35140242 | |
| Pubmed | Analysis of HIV-1 Gag protein interactions via biotin ligase tagging. | 6.66e-06 | 54 | 169 | 5 | 25631074 | |
| Pubmed | PEG10 ASH1L KDM3B LAMB2 E4F1 DNAJC7 ERBIN NCOR2 MACF1 CHD6 PLEC MGA SMURF2 | 7.09e-06 | 591 | 169 | 13 | 15231748 | |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | DNAJC7 SERPINH1 ERBIN HNRNPF HNRNPH1 HNRNPH2 DARS2 NCOR2 EEF1D DDX50 CTNNBL1 SMARCA4 PYCR1 ACIN1 UTP20 PLEC PC | 7.28e-06 | 989 | 169 | 17 | 36424410 |
| Pubmed | Dynein activating adaptor BICD2 controls radial migration of upper-layer cortical neurons in vivo. | 7.40e-06 | 26 | 169 | 4 | 31655624 | |
| Pubmed | 9.07e-06 | 209 | 169 | 8 | 36779422 | ||
| Pubmed | 1.01e-05 | 152 | 169 | 7 | 34299191 | ||
| Pubmed | 1.03e-05 | 59 | 169 | 5 | 26371508 | ||
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | TUT4 PEG10 SYNE1 ZC3H13 HNRNPF HNRNPH1 HNRNPH2 FARSA DDX50 MRPS24 XRN1 ACIN1 MACF1 UTP20 GCN1 | 1.04e-05 | 807 | 169 | 15 | 22681889 |
| Pubmed | SPTAN1 PFAS DNAJC7 SERPINH1 CIT ERBIN GFPT1 HNRNPF HNRNPH1 NCOR2 EEF1D FARSA IPO9 PIK3R2 XRN1 ACIN1 LIMCH1 MGA GCN1 | 1.14e-05 | 1247 | 169 | 19 | 27684187 | |
| Pubmed | 1.15e-05 | 216 | 169 | 8 | 31519766 | ||
| Pubmed | COPG1 PEG10 SPTAN1 PSMA6 PHAX MORC2 GFPT1 PRKD3 EEF1D FARSA IPO9 DOCK7 CTNNBL1 SMARCA4 PYCR1 ACIN1 LIMCH1 PLEC PC GCN1 | 1.24e-05 | 1371 | 169 | 20 | 36244648 | |
| Pubmed | 1.25e-05 | 157 | 169 | 7 | 30186101 | ||
| Pubmed | Analysis of BCL6-interacting proteins by tandem mass spectrometry. | 1.32e-05 | 62 | 169 | 5 | 16147992 | |
| Pubmed | 1.55e-05 | 225 | 169 | 8 | 12168954 | ||
| Interaction | RCOR1 interactions | SPTAN1 CD2AP LAMB2 GEMIN5 EPB41L3 SERPINH1 NCOR2 CCDC88A RABEP1 ARID5B XRN1 DOCK7 SMARCA4 CHD6 PLEC PC MGA GCN1 CCDC93 | 2.73e-08 | 494 | 166 | 19 | int:RCOR1 |
| Interaction | NAA40 interactions | DPYSL2 DPYSL3 PSMA6 KDM3B GEMIN5 PFAS SRCAP PHAX EPB41L3 CIT ERBIN GFPT1 HNRNPF HNRNPH1 ORC2 R3HCC1L NUDT5 DDX50 RABEP1 XRN1 SMARCA4 ACIN1 MACF1 LIMCH1 PC GCN1 EPB41 | 3.13e-08 | 978 | 166 | 27 | int:NAA40 |
| Interaction | IQCB1 interactions | DPYSL2 RPGRIP1L PEG10 SPTAN1 PSMA6 TMEM59 NUCB1 SERPINH1 HNRNPF HNRNPH1 HNRNPH2 IPO9 PLEC GCN1 IQGAP3 NIN | 7.46e-08 | 370 | 166 | 16 | int:IQCB1 |
| Interaction | RHOB interactions | HIP1 SPTAN1 TMEM59 ASH1L ACVR1B CIT ERBIN HNRNPH1 LRP8 JAG2 PRKD3 FARSA FAT1 CCDC88A PIK3R2 JAG1 USP32 DOCK7 MACF1 UTP20 SLC12A7 GOLGA8O IQGAP3 | 4.27e-07 | 840 | 166 | 23 | int:RHOB |
| Interaction | LRRC31 interactions | GEMIN5 CIT HNRNPF XRN1 DOCK7 CRYBG1 UTP20 PLEC TBR1 GCN1 IQGAP3 | 1.10e-06 | 205 | 166 | 11 | int:LRRC31 |
| Interaction | IGLL1 interactions | 2.09e-06 | 12 | 166 | 4 | int:IGLL1 | |
| Interaction | DISC1 interactions | DPYSL2 MYH7 DPYSL3 TSPOAP1 SYNE1 SPTAN1 EPB41L3 DNAJC7 CIT SPTBN4 CCDC88A IPO9 MACF1 PC RBM41 | 2.79e-06 | 429 | 166 | 15 | int:DISC1 |
| Interaction | KCNA3 interactions | MYH7B CD2AP PSMA6 MORC2 EPB41L3 DNAJC7 SERPINH1 ERBIN GFPT1 HNRNPF HNRNPH1 FARSA CCDC88A NUDT5 XRN1 DOCK7 SMARCA4 MACF1 CRYBG3 GCN1 IQGAP3 EPB41 | 2.93e-06 | 871 | 166 | 22 | int:KCNA3 |
| Interaction | YAP1 interactions | DPYSL2 DPYSL3 SPTAN1 CD2AP KDM3B GEMIN5 SRCAP PHAX RUNX3 DNAJC7 CIT ERBIN HNRNPF HNRNPH1 NUDT5 RABEP1 SMARCA4 ACIN1 PLEC PC MGA ARHGAP45 GCN1 SMURF2 EPB41 | 3.53e-06 | 1095 | 166 | 25 | int:YAP1 |
| Interaction | YWHAH interactions | KIF13B DPYSL3 RPGRIP1L SPAST ZC3H13 PARP8 SPTAN1 CD2AP KDM3B EPB41L3 SERPINH1 ERBIN CCDC88A IPO9 RABEP1 XRN1 DOCK7 MACF1 LIMCH1 CRYBG3 PLEC CEP170B EPB41 WNK2 NIN | 3.95e-06 | 1102 | 166 | 25 | int:YWHAH |
| Interaction | PRNP interactions | DPYSL2 COL9A2 SPAST ERAP1 CD2AP PSMA6 ASH1L LAMB2 PFAS DNAJC7 CIT HNRNPH1 EEF1D FAT1 IPO9 NUDT5 CROCC2 EXOC3L4 SCAPER DOCK7 MACF1 TBR1 COPS6 MGA THAP12 | 9.32e-06 | 1158 | 166 | 25 | int:PRNP |
| Interaction | BAP1 interactions | DPYSL2 MYH7 DPYSL3 COPG1 ZC3H13 SPTAN1 CD2AP PSMA6 GEMIN5 PFAS DNAJC7 SERPINH1 HNRNPF HNRNPH1 EEF1D FAT1 IPO9 NUDT5 DOCK7 PYCR1 MACF1 LIMCH1 PLEC TBR1 COPS6 GCN1 IQGAP3 | 9.63e-06 | 1314 | 166 | 27 | int:BAP1 |
| Interaction | ZFAND3 interactions | 9.72e-06 | 17 | 166 | 4 | int:ZFAND3 | |
| Interaction | SIRT7 interactions | DPYSL2 COPG1 ZC3H13 SPTAN1 GEMIN5 PFAS EPB41L3 SERPINH1 GFPT1 HNRNPF XRN1 DOCK7 CTNNBL1 SMARCA4 ACIN1 MACF1 UTP20 PLEC GCN1 | 1.26e-05 | 744 | 166 | 19 | int:SIRT7 |
| Interaction | KIF23 interactions | KIF13B RPGRIP1L ZC3H13 SPTAN1 CD2AP GRB7 CIT GFPT1 HNRNPF HNRNPH2 FARSA DDX50 EXOC3L4 DOCK7 PYCR1 ACIN1 MACF1 TNNC2 PLEC GCN1 THAP12 IQGAP3 NIN | 1.31e-05 | 1031 | 166 | 23 | int:KIF23 |
| Interaction | SNW1 interactions | COPG1 PEG10 SPTAN1 DNAJC7 CIT HNRNPF HNRNPH1 TRIM23 ORC2 NCOR2 IPO9 RABEP1 CTNNBL1 CRNN ACIN1 PLEC COPS6 GCN1 NIN | 1.33e-05 | 747 | 166 | 19 | int:SNW1 |
| Interaction | RNF123 interactions | DPYSL2 ZFYVE27 COPG1 ZC3H13 OBSCN ACVR1B GFPT1 HNRNPF HNRNPH1 DARS2 FAM20C R3HCC1L DQX1 EXOC3L4 ARID5B CTNNBL1 UTP20 CHD6 TBR1 RBM41 | 1.53e-05 | 824 | 166 | 20 | int:RNF123 |
| Interaction | KDM1A interactions | RPGRIP1L CD2AP GEMIN5 EPB41L3 CIT NCOR2 CCDC88A RABEP1 ASB10 ARID5B XRN1 DOCK7 CHD6 CRYBG3 PLEC PC MGA GCN1 CCDC93 CDCA4 NIN | 3.21e-05 | 941 | 166 | 21 | int:KDM1A |
| Interaction | GSK3B interactions | DPYSL2 COPG1 ERAP1 PFAS EPB41L3 ERBIN GFPT1 SPTBN4 EEF1D CCDC88A RABEP1 DOCK7 MACF1 CHD6 CRYBG3 PLEC SMURF2 DKK3 CEP170B NIN | 3.22e-05 | 868 | 166 | 20 | int:GSK3B |
| Interaction | CLNS1A interactions | KDM3B GEMIN5 EPB41L3 HNRNPH1 HNRNPH2 TRNT1 COPS6 LSM10 EPB41 | 3.27e-05 | 193 | 166 | 9 | int:CLNS1A |
| Interaction | MAD2L1 interactions | KDM3B GEMIN5 SRCAP FAT1 CCDC88A NUDT5 MACF1 MGA SMURF2 RBM41 | 4.72e-05 | 252 | 166 | 10 | int:MAD2L1 |
| Interaction | FXR1 interactions | TUT4 MYH7B EPB41L3 CIT HNRNPH1 HNRNPH2 ORC2 NCOR2 FARSA CCDC88A DDX50 CACTIN-AS1 DOCK7 SMARCA4 PYCR1 CEP170B CCDC93 | 4.74e-05 | 679 | 166 | 17 | int:FXR1 |
| Interaction | PPT1 interactions | SPTAN1 PSMA6 CIT HNRNPF HNRNPH1 HNRNPH2 RTL1 DOCK7 PLEC GCN1 | 5.38e-05 | 256 | 166 | 10 | int:PPT1 |
| Interaction | RNF43 interactions | OBSCN DNAJC7 SERPINH1 ERBIN HNRNPF HNRNPH1 HNRNPH2 CCDC88A DDX50 XRN1 MACF1 CRYBG3 GCN1 | 5.55e-05 | 427 | 166 | 13 | int:RNF43 |
| Interaction | RACGAP1 interactions | 5.85e-05 | 208 | 166 | 9 | int:RACGAP1 | |
| Interaction | NUP43 interactions | CENPT SPAST ZC3H13 ASH1L GON4L SRCAP MORC2 CIT NCOR2 CCDC88A NFATC2IP SMARCA4 ACIN1 UTP20 CHD6 MGA | 6.16e-05 | 625 | 166 | 16 | int:NUP43 |
| Interaction | SPDL1 interactions | DPYSL2 DPYSL3 TUT4 COPG1 SPTAN1 LAMB2 HNRNPH1 EEF1D PLEC TBR1 WNK2 | 6.28e-05 | 315 | 166 | 11 | int:SPDL1 |
| Interaction | TOMM20L interactions | 6.31e-05 | 10 | 166 | 3 | int:TOMM20L | |
| Interaction | ERVK-19 interactions | 6.74e-05 | 2 | 166 | 2 | int:ERVK-19 | |
| Interaction | KCTD13 interactions | CACNA1A DPYSL2 DPYSL3 SYNE1 SPTAN1 PSMA6 GEMIN5 EPB41L3 CIT ERBIN HNRNPF HNRNPH1 CADM2 SPTBN4 EEF1D FARSA SCAPER XRN1 DOCK7 SMARCA4 MACF1 LIMCH1 PLEC PC CEP170B WNK2 | 7.41e-05 | 1394 | 166 | 26 | int:KCTD13 |
| Interaction | HECW2 interactions | SPAST SRCAP MORC2 CIT EEF1D SCAPER XRN1 CTNNBL1 MACF1 PC RAD54L | 7.64e-05 | 322 | 166 | 11 | int:HECW2 |
| Interaction | NR2C2 interactions | COPG1 ZC3H13 CD2AP PSMA6 KDM3B GEMIN5 SERPINH1 HNRNPF HNRNPH1 HNRNPH2 DARS2 ORC2 EEF1D FARSA TRNT1 IPO9 DDX50 CTNNBL1 SMARCA4 PYCR1 ACIN1 CRYBG1 CHD6 PLEC PC GCN1 | 8.23e-05 | 1403 | 166 | 26 | int:NR2C2 |
| Interaction | AXDND1 interactions | 8.63e-05 | 11 | 166 | 3 | int:AXDND1 | |
| Interaction | PHLPP1 interactions | SPTAN1 CD2AP GEMIN5 EEF1D CCDC88A XRN1 LIMCH1 PLEC GOLGA8O GCN1 EPB41 | 1.03e-04 | 333 | 166 | 11 | int:PHLPP1 |
| Interaction | CFAP53 interactions | 1.17e-04 | 31 | 166 | 4 | int:CFAP53 | |
| Interaction | SPTA1 interactions | 1.28e-04 | 94 | 166 | 6 | int:SPTA1 | |
| Interaction | GSK3A interactions | PARP8 PFAS ERBIN PRKD3 CCDC88A RABEP1 DOCK7 ACIN1 CRYBG1 MACF1 CRYBG3 CEP170B NIN | 1.28e-04 | 464 | 166 | 13 | int:GSK3A |
| Interaction | PHF21A interactions | CCDC88A RABEP1 ARID5B XRN1 DOCK7 CHD6 CRYBG3 PLEC PC MGA CCDC93 | 1.33e-04 | 343 | 166 | 11 | int:PHF21A |
| Interaction | MAU2 interactions | 1.36e-04 | 136 | 166 | 7 | int:MAU2 | |
| Interaction | DZIP3 interactions | 1.41e-04 | 183 | 166 | 8 | int:DZIP3 | |
| Interaction | CIC interactions | MORC2 EPB41L3 RUNX3 DNAJC7 HNRNPF HNRNPH1 HNRNPH2 ORC2 FARSA DDX50 SMARCA4 ACIN1 TBR1 GTPBP3 MGA EPB41 | 1.45e-04 | 673 | 166 | 16 | int:CIC |
| Interaction | RHOF interactions | HIP1 COPG1 SPTAN1 EPB41L3 ERBIN FAT1 CCDC88A DDX50 PIK3R2 DOCK7 MACF1 UTP20 SLC12A7 GOLGA8O IQGAP3 EPB41 | 1.45e-04 | 673 | 166 | 16 | int:RHOF |
| Interaction | AIRE interactions | 1.52e-04 | 97 | 166 | 6 | int:AIRE | |
| Interaction | PLOD1 interactions | RPGRIP1L KDM3B GRB7 GEMIN5 DNAJC7 CIT HNRNPH1 HNRNPH2 PLEC NIN | 1.59e-04 | 292 | 166 | 10 | int:PLOD1 |
| Interaction | SMURF1 interactions | HIP1 SPTAN1 ACVR1B EPB41L3 RUNX3 DNAJC7 HNRNPF HNRNPH1 HNRNPH2 EEF1D CCDC88A NUDT5 RABEP1 SMURF2 | 1.70e-04 | 544 | 166 | 14 | int:SMURF1 |
| Interaction | DYRK1A interactions | DPYSL2 DPYSL3 SPTAN1 TMEM59 NUCB1 DNAJC7 CIT HNRNPH1 NCOR2 USP32 XRN1 DOCK7 LIMCH1 DKK3 | 1.98e-04 | 552 | 166 | 14 | int:DYRK1A |
| Interaction | WWTR1 interactions | SPTAN1 CD2AP GEMIN5 SRCAP ERBIN NUDT5 RABEP1 XRN1 DOCK7 SMARCA4 GCN1 EPB41 | 2.03e-04 | 422 | 166 | 12 | int:WWTR1 |
| Interaction | SF1 interactions | ERAP1 CIT GFPT1 HNRNPF HNRNPH1 HNRNPH2 TRIM23 NCOR2 CTNNBL1 EPB41 | 2.20e-04 | 304 | 166 | 10 | int:SF1 |
| Interaction | KLHL35 interactions | 2.32e-04 | 15 | 166 | 3 | int:KLHL35 | |
| Interaction | NEUROG3 interactions | 2.39e-04 | 149 | 166 | 7 | int:NEUROG3 | |
| Interaction | PLEC interactions | HIP1 SPTAN1 ASH1L CIT AXDND1 EEF1D CCDC88A RABEP1 MACF1 PLEC MYO18B FILIP1L | 2.42e-04 | 430 | 166 | 12 | int:PLEC |
| Interaction | BIRC3 interactions | COPG1 SYNE1 SPTAN1 PSMA6 GEMIN5 PFAS DNAJC7 SERPINH1 GFPT1 HNRNPF HNRNPH1 DARS2 NCOR2 EEF1D FARSA IPO9 DDX50 CTNNBL1 SMARCA4 PYCR1 ACIN1 UTP20 PC GCN1 | 2.48e-04 | 1334 | 166 | 24 | int:BIRC3 |
| Interaction | C11orf52 interactions | SPTAN1 EPB41L3 ERBIN JAG2 CCDC88A PIK3R2 DOCK7 MACF1 SLC12A7 EPB41 | 2.64e-04 | 311 | 166 | 10 | int:C11orf52 |
| Interaction | MIRLET7A1 interactions | 2.73e-04 | 108 | 166 | 6 | int:MIRLET7A1 | |
| Interaction | RHOD interactions | SPTAN1 GOLGA8R EPB41L3 ERBIN JAG2 CCDC88A PIK3R2 DOCK7 MACF1 UTP20 SLC12A7 SMURF2 IQGAP3 EPB41 | 2.85e-04 | 572 | 166 | 14 | int:RHOD |
| Interaction | NHLRC2 interactions | DPYSL2 COPG1 PSMA6 GOLGA8R RUNX3 DNAJC7 HNRNPF SPTBN4 CRYBG1 MACF1 CRYBG3 | 2.88e-04 | 375 | 166 | 11 | int:NHLRC2 |
| Interaction | MTDH interactions | CYP4V2 SPAST SYNE1 OBSCN GRB7 CIT FAM20C IPO9 DDX50 JAG1 ACIN1 PLEC WNK2 | 2.91e-04 | 505 | 166 | 13 | int:MTDH |
| Interaction | SNRPC interactions | OBSCN GEMIN5 CIT HNRNPF HNRNPH1 HNRNPH2 CTNNBL1 ACIN1 MACF1 TNNC2 COPS6 NIN | 2.98e-04 | 440 | 166 | 12 | int:SNRPC |
| Interaction | CYLD interactions | DPYSL2 COPG1 SPTAN1 PSMA6 GEMIN5 SERPINH1 CIT HNRNPF HNRNPH1 HNRNPH2 EEF1D FARSA TAF7L PDP2 PLEC MGA GCN1 NIN | 3.00e-04 | 868 | 166 | 18 | int:CYLD |
| Interaction | TNIK interactions | CACNA1A DPYSL2 DPYSL3 SYNE1 SPTAN1 CIT NCOR2 DOCK7 MACF1 MGA CEP170B | 3.30e-04 | 381 | 166 | 11 | int:TNIK |
| Interaction | AIMP2 interactions | DPYSL2 CD2AP PFAS DNAJC7 HNRNPF HNRNPH1 HNRNPH2 DARS2 FARSA IPO9 RABEP1 SMURF2 | 3.36e-04 | 446 | 166 | 12 | int:AIMP2 |
| Interaction | CIT interactions | HIP1 SYNE1 ZC3H13 SPTAN1 ASH1L PFAS SERPINH1 CIT GFPT1 HNRNPF HNRNPH2 SPTBN4 ORC2 EEF1D DDX50 CTNNBL1 SMARCA4 PYCR1 ACIN1 MACF1 UTP20 PLEC GCN1 UTP14C NIN | 3.47e-04 | 1450 | 166 | 25 | int:CIT |
| Interaction | ARF6 interactions | KIF13B COPG1 EPB41L3 ERBIN HNRNPH1 LRP8 CCDC88A IPO9 PIK3R2 DOCK7 ATG4C RAB11FIP4 SLC12A7 EPB41 | 3.51e-04 | 584 | 166 | 14 | int:ARF6 |
| Interaction | MIR20A interactions | 3.64e-04 | 74 | 166 | 5 | int:MIR20A | |
| Interaction | MED4 interactions | DPYSL3 ZC3H13 SPTAN1 CD2AP GEMIN5 EPB41L3 ERBIN HNRNPH1 XRN1 CTNNBL1 EPB41 NIN | 3.64e-04 | 450 | 166 | 12 | int:MED4 |
| Interaction | AGRN interactions | 3.81e-04 | 267 | 166 | 9 | int:AGRN | |
| Interaction | EGLN3 interactions | TUT4 COPG1 NUCB1 KDM3B PFAS DNAJC7 SERPINH1 ERBIN GFPT1 TUBGCP6 NCOR2 FARSA CCDC88A R3HCC1L PIK3R2 ARID5B XRN1 DOCK7 MGA GCN1 IQGAP3 CEP170B NIN | 4.09e-04 | 1296 | 166 | 23 | int:EGLN3 |
| Interaction | MIR429 interactions | 4.11e-04 | 76 | 166 | 5 | int:MIR429 | |
| Interaction | TOP3B interactions | HIP1 SPTAN1 OBSCN KDM3B LAMB2 GEMIN5 PFAS SRCAP ZNF236 CIT JAG2 NCOR2 FAM20C FAT1 NBEAL2 XRN1 ACIN1 PLEC PC LSM10 GCN1 SMURF2 IQGAP3 CEP170B WNK2 | 4.25e-04 | 1470 | 166 | 25 | int:TOP3B |
| Interaction | TRIM28 interactions | KIF13B COPG1 SPTAN1 GEMIN5 PFAS SRCAP MORC2 CIT GFPT1 HNRNPF HNRNPH1 HNRNPH2 TRIM23 DARS2 EEF1D FARSA MRPS24 CTNNBL1 SMARCA4 UTP20 PC GCN1 SMURF2 IQGAP3 CDCA4 | 4.42e-04 | 1474 | 166 | 25 | int:TRIM28 |
| Cytoband | 17q22-q23 | 1.98e-04 | 6 | 168 | 2 | 17q22-q23 | |
| Cytoband | 1p33-p32 | 4.71e-04 | 9 | 168 | 2 | 1p33-p32 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr15q13 | 5.16e-04 | 100 | 168 | 4 | chr15q13 | |
| GeneFamily | EF-hand domain containing | 3.14e-05 | 219 | 101 | 8 | 863 | |
| GeneFamily | Beta-gamma crystallin domain containing | 9.24e-05 | 3 | 101 | 2 | 1360 | |
| GeneFamily | T-boxes | 1.30e-04 | 18 | 101 | 3 | 766 | |
| GeneFamily | Erythrocyte membrane protein band 4.1|FERM domain containing | 1.84e-04 | 4 | 101 | 2 | 951 | |
| GeneFamily | EF-hand domain containing|Spectrins | 6.37e-04 | 7 | 101 | 2 | 1113 | |
| GeneFamily | EF-hand domain containing|Plakins | 8.46e-04 | 8 | 101 | 2 | 939 | |
| GeneFamily | Myosin heavy chains | 3.09e-03 | 15 | 101 | 2 | 1098 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 3.24e-03 | 53 | 101 | 3 | 532 | |
| Coexpression | GSE2770_IL12_ACT_VS_ACT_CD4_TCELL_6H_DN | COL9A2 GRB7 SEMA3G AK7 HNRNPH1 USP32 ARID5B BEX4 SMURF2 EPB41 | 4.11e-07 | 192 | 165 | 10 | M6064 |
| Coexpression | GSE17186_CD21LOW_VS_CD21HIGH_TRANSITIONAL_BCELL_CORD_BLOOD_UP | CYP4V2 DPYSL2 NUCB1 ALS2CL GFPT1 NBEAL2 EXOC3L4 CRYBG3 DKK3 RAD54L | 5.98e-07 | 200 | 165 | 10 | M7192 |
| Coexpression | GSE12845_IGD_NEG_BLOOD_VS_DARKZONE_GC_TONSIL_BCELL_DN | 5.05e-06 | 199 | 165 | 9 | M3197 | |
| Coexpression | GSE411_WT_VS_SOCS3_KO_MACROPHAGE_DN | 5.26e-06 | 200 | 165 | 9 | M5991 | |
| Coexpression | GSE40273_GATA1_KO_VS_WT_TREG_DN | 5.26e-06 | 200 | 165 | 9 | M9133 | |
| Coexpression | FAN_EMBRYONIC_CTX_EX_4_EXCITATORY_NEURON | 1.08e-05 | 166 | 165 | 8 | M39026 | |
| Coexpression | BENPORATH_NANOG_TARGETS | CACNA1A DPYSL2 DPYSL3 PARP8 TMEM59 SERPINH1 HNRNPH2 DARS2 EOMES FAM20C FARSA FAT1 NUDT5 NDUFAF7 PIK3R2 ARID5B ATG4C GTPBP3 CCDC93 | 1.58e-05 | 988 | 165 | 19 | M6616 |
| Coexpression | DE_YY1_TARGETS_DN | 2.75e-05 | 93 | 165 | 6 | M3278 | |
| Coexpression | GSE2706_LPS_VS_R848_AND_LPS_2H_STIM_DC_UP | 2.97e-05 | 191 | 165 | 8 | M4722 | |
| Coexpression | AIZARANI_LIVER_C29_MVECS_2 | DPYSL2 DPYSL3 SPTAN1 LAMB2 ARID5B MMRN2 LIMCH1 PLEC DKK3 FILIP1L | 3.12e-05 | 313 | 165 | 10 | M39128 |
| Coexpression | ZHONG_PFC_C3_ASTROCYTE | CACNA1A DPYSL3 TSPOAP1 OBSCN GEMIN5 JAG2 TUBGCP6 SPTBN4 NCOR2 NFATC2IP GCN1 | 3.82e-05 | 389 | 165 | 11 | M39102 |
| Coexpression | BILD_MYC_ONCOGENIC_SIGNATURE | 5.62e-05 | 209 | 165 | 8 | M2069 | |
| Coexpression | GSE7348_UNSTIM_VS_TOLERIZED_AND_LPS_STIM_MACROPHAGE_UP | 7.76e-05 | 162 | 165 | 7 | M6847 | |
| Coexpression | BONOME_OVARIAN_CANCER_SURVIVAL_SUBOPTIMAL_DEBULKING | OXLD1 SYNE1 EPB41L3 HNRNPH1 PRKD3 FARSA PIK3R2 NBEAL2 SCAPER LIMCH1 RAD54L FILIP1L | 9.21e-05 | 506 | 165 | 12 | M253 |
| Coexpression | MURARO_PANCREAS_ENDOTHELIAL_CELL | DPYSL3 HIP1 SEMA3G SERPINH1 ERBIN JAG1 MMRN2 MACF1 SLC12A7 DKK3 | 1.05e-04 | 362 | 165 | 10 | M39176 |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | TUT4 TSPOAP1 SYNE1 ERBIN GOLGA8Q EOMES MACF1 GOLGA8O ARHGAP45 THAP12 | 1.51e-09 | 177 | 168 | 10 | d3e6c768b88b7906f3c7fdd00ba20842212c14b1 |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | TUT4 TSPOAP1 SYNE1 ERBIN GOLGA8Q EOMES MACF1 GOLGA8O ARHGAP45 THAP12 | 1.51e-09 | 177 | 168 | 10 | f8f101c772c043636bedd6b2ec81409b1d2599bf |
| ToppCell | COVID-19_Mild-Lymphoid_T/NK-NK_activated|COVID-19_Mild / Disease group, lineage and cell class | TUT4 TSPOAP1 SYNE1 ERBIN GOLGA8Q EOMES MACF1 GOLGA8O ARHGAP45 THAP12 | 1.51e-09 | 177 | 168 | 10 | 6978a22fef40c8b455342373abe7593f5ede0fa4 |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | TUT4 TSPOAP1 SYNE1 ERBIN GOLGA8Q EOMES MACF1 GOLGA8O ARHGAP45 THAP12 | 1.51e-09 | 177 | 168 | 10 | 936ab2b180a052387124f68d0c7f41c0b164e748 |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | TUT4 TSPOAP1 SYNE1 ERBIN GOLGA8Q EOMES MACF1 GOLGA8O ARHGAP45 THAP12 | 1.51e-09 | 177 | 168 | 10 | d5aeda113afaa2425874394610344570c9078478 |
| ToppCell | COVID-19_Mild-NK_activated|COVID-19_Mild / Disease condition and Cell class | TUT4 TSPOAP1 SYNE1 ERBIN GOLGA8Q EOMES MACF1 GOLGA8O ARHGAP45 THAP12 | 2.09e-09 | 183 | 168 | 10 | 22bd05135906d0ecc4ba8c2e0a666093d1bf3b8f |
| ToppCell | COVID_non-vent-Lymphocytic-ILC|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | TSPOAP1 SYNE1 PARP8 GOLGA8R RUNX3 GOLGA8Q GOLGA8N EOMES MACF1 GOLGA8O | 4.68e-09 | 199 | 168 | 10 | df4f7d5be099e3e6054f3b812ccf70251664e4c0 |
| ToppCell | COVID_non-vent-Lymphocytic-ILC-NK_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | TSPOAP1 SYNE1 PARP8 GOLGA8R RUNX3 GOLGA8Q GOLGA8N EOMES MACF1 GOLGA8O | 4.68e-09 | 199 | 168 | 10 | ed35d747f11f6ea6a5cb7061057f0a98d9e0db99 |
| ToppCell | COVID-19_Severe-Lymphoid_T/NK-gd_T|COVID-19_Severe / Disease group, lineage and cell class | 5.85e-08 | 195 | 168 | 9 | 9990440bda7fac5d00ef80444fab07459be625e1 | |
| ToppCell | COVID_vent-Lymphocytic-ILC|COVID_vent / Disease condition, Lineage, Cell class and subclass | TSPOAP1 SYNE1 GOLGA8R RUNX3 GOLGA8Q GOLGA8N EOMES MACF1 GOLGA8O | 6.97e-08 | 199 | 168 | 9 | e3ff7fa1b1de1aaf6b46cdf49afa95bad457728a |
| ToppCell | COVID_vent-Lymphocytic-ILC-NK_cell|COVID_vent / Disease condition, Lineage, Cell class and subclass | TSPOAP1 SYNE1 GOLGA8R RUNX3 GOLGA8Q GOLGA8N EOMES MACF1 GOLGA8O | 6.97e-08 | 199 | 168 | 9 | 5f914962e2572b0c6372465b81b7496fa663d93c |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_activated|COVID-19_Mild / Disease, condition lineage and cell class | 7.27e-08 | 200 | 168 | 9 | 2281debd86e5d92e8fe0397aec9ef670800f7471 | |
| ToppCell | 3'_v3-Lung-Lymphocytic_T_CD4-T_CD4/CD8|Lung / Manually curated celltypes from each tissue | 1.13e-07 | 151 | 168 | 8 | 999c11d19b61d6b130ad5e623afa83cbdfe13cdd | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.71e-07 | 182 | 168 | 8 | f8c73baaaca145e2efc48f10f636feb79c8fc779 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.33e-07 | 185 | 168 | 8 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.93e-07 | 195 | 168 | 8 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.24e-07 | 196 | 168 | 8 | 418e8e0a51c5cb60e3b903e7d2d800dc8b9f3d5c | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.24e-07 | 196 | 168 | 8 | 581fc8c8d42005aacd7b401a2c9d1fc331fb4af7 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 8.24e-07 | 196 | 168 | 8 | 6beaf0c2799424c59819b286fbb5c1a83d85e4d1 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.24e-07 | 196 | 168 | 8 | c35f2349dfe35baa845f790b9f31673dceac54c0 | |
| ToppCell | COVID_non-vent-Lymphocytic|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 8.56e-07 | 197 | 168 | 8 | c672915f8c8c1e948d251f6eaf9f84a5600c1193 | |
| ToppCell | healthy_donor-Lymphocytic-ILC-NK_cell|healthy_donor / Disease condition, Lineage, Cell class and subclass | 8.89e-07 | 198 | 168 | 8 | d7053a898e04478c577381085f615edaad3cdc5b | |
| ToppCell | facs-Tongue-nan-3m-Epithelial-basal_cell_of_epidermis|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.89e-07 | 198 | 168 | 8 | 22559b161e67b49fe8028bfaf861e069063599f5 | |
| ToppCell | healthy_donor-Lymphocytic-ILC|healthy_donor / Disease condition, Lineage, Cell class and subclass | 8.89e-07 | 198 | 168 | 8 | aa33be29e26f1b8facfc894413099083ae3bbb1b | |
| ToppCell | kidney_cells-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.24e-07 | 199 | 168 | 8 | 9b02acae6325b0ac9642438a4431285ff396e5fe | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma-osteochondral_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 9.59e-07 | 200 | 168 | 8 | ad3fb8ef0be45032369d1325024787fbe1dfb8d6 | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Peri/Epineurial_-NAF_endoneurial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.06e-06 | 140 | 168 | 7 | 0e1e9281de87df178ac41ed6b697b4fa09be2749 | |
| ToppCell | E15.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.00e-06 | 154 | 168 | 7 | e65e4636646164610f33f7bbac0d879a3ea55986 | |
| ToppCell | 367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 3.56e-06 | 168 | 168 | 7 | 2fb2d916eb5000a637240d38e47a9b4f61f9f83f | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 4.00e-06 | 171 | 168 | 7 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.47e-06 | 184 | 168 | 7 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | COVID-19_Severe-gd_T|COVID-19_Severe / Disease condition and Cell class | 6.47e-06 | 184 | 168 | 7 | 791f1bcb954aadc63d4117c400537d036f68734d | |
| ToppCell | RV-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 7.00e-06 | 122 | 168 | 6 | 1cb1dd03b2aaedbe04f3ed907568c3b7f54767b3 | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-Treg_cell_3|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 7.20e-06 | 187 | 168 | 7 | 1eed2c1a05e80a7c8f639437c117afe0c18dfb0c | |
| ToppCell | facs-Heart-Unknown-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.20e-06 | 187 | 168 | 7 | 0ffb988e0da2c7205c3515eca8e9851739bff5c5 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 7.71e-06 | 189 | 168 | 7 | 5e80c47f63980904c4c1ff02c201b67b456a0974 | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.71e-06 | 189 | 168 | 7 | feedac2751ed770f80bc56fec31662b5b3826f58 | |
| ToppCell | (2)_NK/T-(210)_NKT_cell|(2)_NK/T / immune cells in Peripheral Blood (logTPM normalization) | 7.71e-06 | 189 | 168 | 7 | fa72e87e1e8cd7cbddae7b47e19cf90d181820a7 | |
| ToppCell | ILEUM-non-inflamed-(1)_T_cell-(1)_CD8_Trm|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 7.71e-06 | 189 | 168 | 7 | 2c8a2fb76ea002bac554bc1c761ce960b5e116e1 | |
| ToppCell | (2)_NK/T-(21)_NKT_cell|(2)_NK/T / immune cells in Peripheral Blood (logTPM normalization) | 7.71e-06 | 189 | 168 | 7 | b37ad24898a14a4a3b2d6cea2637de2471f76e20 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 7.98e-06 | 190 | 168 | 7 | de5ef606a002f85c2e0e3a36c1f259d0b85a76ff | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.98e-06 | 190 | 168 | 7 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | 7.98e-06 | 190 | 168 | 7 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | 8.26e-06 | 191 | 168 | 7 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-CD207+CD1a+_LCs|Myeloid_cells / Location, Cell class and cell subclass | 8.55e-06 | 192 | 168 | 7 | f18da8db573e584c8b90df0814afcf020360108e | |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|LV / Chamber and Cluster_Paper | 8.55e-06 | 192 | 168 | 7 | ad19e2c1d36a0566c9b12ced10db78f4781c8ea6 | |
| ToppCell | droplet-Kidney-nan-18m-Endothelial-kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.55e-06 | 192 | 168 | 7 | 144503af50274eaed5cf6effa892c640eab28663 | |
| ToppCell | droplet-Kidney-nan-18m-Endothelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.55e-06 | 192 | 168 | 7 | c96736bb3a6bb052678b1b078f7823063ca69e6d | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.84e-06 | 193 | 168 | 7 | 471e65f02937bc18d7c5facdacdf1df58cf0f839 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.84e-06 | 193 | 168 | 7 | fe451b3295d77b2bd1ac25cf29310c85835a45fe | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-T_lymphocytic-CD8-positive,_alpha-beta_T_cell|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.84e-06 | 193 | 168 | 7 | a594f89a18273797506287d9e22f72abe53e4920 | |
| ToppCell | droplet-Pancreas-Endocrine-21m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.14e-06 | 194 | 168 | 7 | 3a3ecedcdc7691cf21775818b598208fcb980c29 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.14e-06 | 194 | 168 | 7 | 0b023de48ed8a550d169bbe954881eb04bf4f981 | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-lymphocytic-T_lymphocytic-type_I_NK_T_cell|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 9.46e-06 | 195 | 168 | 7 | 0a72b8446399807ace5b6c72f865bb40dbd9e92d | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.46e-06 | 195 | 168 | 7 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | systemic_lupus_erythematosus-flare|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.04e-05 | 198 | 168 | 7 | 4c93ee921d56132d80832d8e94563f32ccf13bbc | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.04e-05 | 198 | 168 | 7 | 5e781583908c4ee107d986904a646a7c6b8e3591 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.08e-05 | 199 | 168 | 7 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | healthy_donor-Lymphocytic|healthy_donor / Disease condition, Lineage, Cell class and subclass | 1.08e-05 | 199 | 168 | 7 | 2841e16d54acd344ba454f024e285c28abc37319 | |
| ToppCell | mild-MAIT|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.08e-05 | 199 | 168 | 7 | cbe1fb6d2c5fca7a1baf1ad20afcdf8e8e11bd84 | |
| ToppCell | COVID-19_Moderate|World / disease group, cell group and cell class | 1.08e-05 | 199 | 168 | 7 | 952fac67588ad5676f5939e3c7f8bac803c27064 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Vein|LPS_only / Treatment groups by lineage, cell group, cell type | 1.11e-05 | 200 | 168 | 7 | b036f5e22c95a3b14391785b6e91aa183b9bc9a8 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.11e-05 | 200 | 168 | 7 | 93e13937ec74418a697c37d56f57509fb2154780 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_only / Treatment groups by lineage, cell group, cell type | 1.11e-05 | 200 | 168 | 7 | 593bf6a7c557437db9a9249a5058a46014179ef6 | |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-T/NK-gd_T|COVID-19_Severe / Disease, condition lineage and cell class | 1.11e-05 | 200 | 168 | 7 | f72bc3f6606ae77fe1b0a972e35b3ce0727804d9 | |
| ToppCell | ILEUM-non-inflamed-(3)_MNP-(3)_moDC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.25e-05 | 135 | 168 | 6 | b7a792a7c0c22d8b703509f134115f0e394d7de0 | |
| ToppCell | PBMC-Severe-Myeloid-cDC-cDC-cDC_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.94e-05 | 157 | 168 | 6 | f896997490bb2eec598c6581f161220e70f9a991 | |
| ToppCell | PBMC-Severe-Myeloid-cDC-cDC-cDC_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.94e-05 | 157 | 168 | 6 | 14a8516346a89a89f1119b744625bd9844a74a03 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.04e-05 | 158 | 168 | 6 | 7274f020c0ecf216da4b6689c62bc5f49c29b6f3 | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_Tubular-6|TCGA-Stomach / Sample_Type by Project: Shred V9 | 3.15e-05 | 159 | 168 | 6 | 655c0749c238bd68cb797adb83e25a23b8a3cc9d | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 3.50e-05 | 162 | 168 | 6 | b4535bcb3f469bc139e73f1122f4070013e5a1de | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.88e-05 | 165 | 168 | 6 | a74751e0ec857aa974bec04ccc747c004a8f6e01 | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.58e-05 | 170 | 168 | 6 | 3f15242a1d3e4e9871d9170b2ef05842fb609c29 | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.56e-05 | 176 | 168 | 6 | 96779273b94345250cf53ba671203345b43d9e00 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.92e-05 | 178 | 168 | 6 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | droplet-Fat-Gat-18m-Endothelial-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.11e-05 | 179 | 168 | 6 | 08cf9986804a6417a9afb19b50c69a3554f71ec6 | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-CD207+CD1a+_LCs|metastatic_Lymph_Node / Location, Cell class and cell subclass | 6.30e-05 | 180 | 168 | 6 | 289f8c4b53ffd164fee1f459a9315c0deb5f76d0 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.30e-05 | 180 | 168 | 6 | 788d5fbf688365b5d92d3aa19b9f8e9448f8be5a | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue | 6.49e-05 | 181 | 168 | 6 | f2315414e714ac86211546a935660c4be6e85f1b | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.69e-05 | 182 | 168 | 6 | e78ba2c5cae480c16a596ce7c3bf2d480becacf4 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.69e-05 | 182 | 168 | 6 | 1710eab3037a87609d21838be2d2d29c3bc36651 | |
| ToppCell | droplet-Spleen-nan-18m|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.69e-05 | 182 | 168 | 6 | eeb5dfa4539e9ca5220f26bc2b65717ddcf13b6c | |
| ToppCell | COVID-19_Mild-Lymphoid_T/NK-CD4+_T_activated|COVID-19_Mild / Disease group, lineage and cell class | 6.90e-05 | 183 | 168 | 6 | 7717fce227b4e02ed41baad8ae7dd2e22bd7c13e | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.90e-05 | 183 | 168 | 6 | 28cbf909424f3be4491d49832f0aca0386560814 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.90e-05 | 183 | 168 | 6 | b5ede5a0048c585b73c00e88aeddbcaf669347b1 | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.90e-05 | 183 | 168 | 6 | 3fa608aa6b119869ec3280dc388dfee57160e63a | |
| ToppCell | 3'-Child09-12-SmallIntestine-Endothelial-blood_vessel_EC-Mature_arterial_EC|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.11e-05 | 184 | 168 | 6 | 842473fa415575441b595073a994b6d621169776 | |
| ToppCell | ILEUM-inflamed-(1)_T_cell-(1)_CD8_Trm|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 7.11e-05 | 184 | 168 | 6 | cef3ee2a4a0af961aa3b4c92150d423e841ae8c1 | |
| ToppCell | Control-Neu_4|World / 5 Neutrophil clusters in COVID-19 patients | 7.11e-05 | 184 | 168 | 6 | ce7f044956613118ee2e9fb6af2455c3166cb414 | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 7.11e-05 | 184 | 168 | 6 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | droplet-Bladder-BLADDER-1m-Epithelial-luminal_bladder_epithelial_cell_(umbrella_cell)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.11e-05 | 184 | 168 | 6 | 382b1e90b3f437af596750669c0465a169d97095 | |
| ToppCell | COVID-19-Heart-CM_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.11e-05 | 184 | 168 | 6 | e737f0f14c49b07bbb04a165083ac32210bc5690 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l15|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.23e-05 | 114 | 168 | 5 | 84318a25a701331ccd5e68221239c543b9c0cc54 | |
| ToppCell | COVID-19-Heart-CM_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.33e-05 | 185 | 168 | 6 | 549eeb521c3985bff396ea0f202db21822efa51f | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.33e-05 | 185 | 168 | 6 | f98af3146ec2f44c30d31a662fb9c4fa3ca4f706 | |
| ToppCell | normal-na-Lymphocytic_T-CytoT_GZMH+-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 7.33e-05 | 185 | 168 | 6 | 097d628f92e13250c15b550f2fd1f4225fc07558 | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 7.33e-05 | 185 | 168 | 6 | 6baccb26f999145e51b91d94315bf8d4655bef31 | |
| ToppCell | facs-Heart-Unknown|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.77e-05 | 187 | 168 | 6 | 362e56426a568423a81e8a30e3ecf99b76135843 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.77e-05 | 187 | 168 | 6 | e93cad16a087d1443cbf4e1690dc1b35d7a84c41 | |
| ToppCell | facs-Heart-Unknown-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.77e-05 | 187 | 168 | 6 | c004567767b89f3d89f5c7b28d952f3445957e1e | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.15e-04 | 50 | 104 | 5 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_4 | |
| Drug | Fluphenazine dihydrochloride [146-56-5]; Down 200; 7.8uM; MCF7; HT_HG-U133A | HIP1 SPAST ACVR1B SRCAP TRIM23 NDUFAF7 PIK3R2 NBEAL2 GTPBP3 ARHGAP45 RAPGEFL1 | 1.67e-07 | 196 | 162 | 11 | 7234_DN |
| Drug | Methylergometrine maleate [113-42-8]; Down 200; 8.8uM; PC3; HT_HG-U133A | SPTAN1 EPB41L3 ALS2CL SERPINH1 TRIM23 FANCC FARSA RABEP1 NDUFAF7 BEX4 | 1.29e-06 | 193 | 162 | 10 | 6704_DN |
| Disease | Adenoid Cystic Carcinoma | 1.69e-05 | 100 | 158 | 6 | C0010606 | |
| Disease | PR interval | KIF13B MYH7 OBSCN LAMB2 EOMES FAT1 MACF1 CHD6 PLEC SLC12A7 THAP12 | 7.79e-05 | 495 | 158 | 11 | EFO_0004462 |
| Disease | EMILIN-3 measurement | 8.52e-05 | 3 | 158 | 2 | EFO_0801563 | |
| Disease | Hypertrophic Cardiomyopathy | 2.51e-04 | 57 | 158 | 4 | C0007194 | |
| Disease | Myasthenic Syndromes, Congenital | 2.81e-04 | 24 | 158 | 3 | C0751882 | |
| Disease | glutaminyl-peptide cyclotransferase measurement | 2.82e-04 | 5 | 158 | 2 | EFO_0802570 | |
| Disease | cerebellar ataxia (is_implicated_in) | 2.82e-04 | 5 | 158 | 2 | DOID:0050753 (is_implicated_in) | |
| Disease | inflammatory bowel disease (implicated_via_orthology) | 3.18e-04 | 25 | 158 | 3 | DOID:0050589 (implicated_via_orthology) | |
| Disease | Glioblastoma Multiforme | 3.35e-04 | 111 | 158 | 5 | C1621958 | |
| Disease | right ventricular ejection fraction measurement | 5.50e-04 | 30 | 158 | 3 | EFO_0021816 | |
| Disease | X-Linked Emery-Dreifuss Muscular Dystrophy | 5.88e-04 | 7 | 158 | 2 | C0751337 | |
| Disease | joint hypermobility measurement | 7.30e-04 | 33 | 158 | 3 | EFO_0007905 | |
| Disease | cerebellar ataxia (implicated_via_orthology) | 7.81e-04 | 8 | 158 | 2 | DOID:0050753 (implicated_via_orthology) | |
| Disease | right ventricular systolic volume measurement | 8.69e-04 | 35 | 158 | 3 | EFO_0021815 | |
| Disease | Glioblastoma | 8.70e-04 | 79 | 158 | 4 | C0017636 | |
| Disease | dilated cardiomyopathy (implicated_via_orthology) | 9.12e-04 | 80 | 158 | 4 | DOID:12930 (implicated_via_orthology) | |
| Disease | bipolar I disorder | 9.95e-04 | 141 | 158 | 5 | EFO_0009963 | |
| Disease | Giant Cell Glioblastoma | 1.09e-03 | 84 | 158 | 4 | C0334588 | |
| Disease | autosomal dominant hyaline body myopathy (implicated_via_orthology) | 1.25e-03 | 10 | 158 | 2 | DOID:0111269 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2B3 (implicated_via_orthology) | 1.25e-03 | 10 | 158 | 2 | DOID:0111602 (implicated_via_orthology) | |
| Disease | pancreatic hormone measurement | 1.25e-03 | 10 | 158 | 2 | EFO_0020621 | |
| Disease | distal arthrogryposis type 1 (implicated_via_orthology) | 1.25e-03 | 10 | 158 | 2 | DOID:0111596 (implicated_via_orthology) | |
| Disease | dilated cardiomyopathy 1S (implicated_via_orthology) | 1.25e-03 | 10 | 158 | 2 | DOID:0110454 (implicated_via_orthology) | |
| Disease | congenital myopathy 6 (implicated_via_orthology) | 1.25e-03 | 10 | 158 | 2 | DOID:0080719 (implicated_via_orthology) | |
| Disease | inclusion body myositis (implicated_via_orthology) | 1.25e-03 | 10 | 158 | 2 | DOID:3429 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2A (implicated_via_orthology) | 1.25e-03 | 10 | 158 | 2 | DOID:0111605 (implicated_via_orthology) | |
| Disease | familial hypertrophic cardiomyopathy (implicated_via_orthology) | 1.25e-03 | 10 | 158 | 2 | DOID:0080326 (implicated_via_orthology) | |
| Disease | Ankylosing spondylitis | 1.52e-03 | 11 | 158 | 2 | C0038013 | |
| Disease | triacylglycerol 56:2 measurement | 1.52e-03 | 11 | 158 | 2 | EFO_0010429 | |
| Disease | quality of life during menstruation measurement, acne | 1.52e-03 | 11 | 158 | 2 | EFO_0003894, EFO_0009366 | |
| Disease | Neurodevelopmental Disorders | 1.60e-03 | 93 | 158 | 4 | C1535926 | |
| Disease | Dental enamel hypoplasia | 1.82e-03 | 12 | 158 | 2 | EFO_1001304 | |
| Disease | distal myopathy (implicated_via_orthology) | 1.82e-03 | 12 | 158 | 2 | DOID:11720 (implicated_via_orthology) | |
| Disease | myotonia congenita (implicated_via_orthology) | 1.82e-03 | 12 | 158 | 2 | DOID:2106 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of breast | SPAST CYP2D6 SYNE1 SPTAN1 OBSCN GRB7 EPB41L3 ALS2CL EOMES JAG2 JAG1 MACF1 UTP20 RAD54L | 1.97e-03 | 1074 | 158 | 14 | C0006142 |
| Disease | restrictive cardiomyopathy (implicated_via_orthology) | 2.14e-03 | 13 | 158 | 2 | DOID:397 (implicated_via_orthology) | |
| Disease | – | 2.14e-03 | 13 | 158 | 2 | 608446 | |
| Disease | Myocardial infarction, susceptibility to | 2.14e-03 | 13 | 158 | 2 | cv:C1832662 | |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 2.32e-03 | 49 | 158 | 3 | DOID:0060037 (implicated_via_orthology) | |
| Disease | level of Phosphatidylcholine (18:1_18:2) in blood serum | 2.49e-03 | 14 | 158 | 2 | OBA_2045100 | |
| Disease | Left ventricular noncompaction | 2.49e-03 | 14 | 158 | 2 | C1960469 | |
| Disease | African Burkitt's lymphoma | 2.86e-03 | 15 | 158 | 2 | C0343640 | |
| Disease | distal arthrogryposis (implicated_via_orthology) | 2.86e-03 | 15 | 158 | 2 | DOID:0050646 (implicated_via_orthology) | |
| Disease | Gastro-enteropancreatic neuroendocrine tumor | 2.86e-03 | 15 | 158 | 2 | C2930967 | |
| Disease | Burkitt Leukemia | 2.86e-03 | 15 | 158 | 2 | C4721444 | |
| Disease | Intellectual Disability | 2.91e-03 | 447 | 158 | 8 | C3714756 | |
| Disease | brain measurement, neuroimaging measurement | 2.95e-03 | 550 | 158 | 9 | EFO_0004346, EFO_0004464 | |
| Disease | total blood protein measurement | 2.99e-03 | 449 | 158 | 8 | EFO_0004536 | |
| Disease | pancreatic cancer (is_implicated_in) | 3.14e-03 | 112 | 158 | 4 | DOID:1793 (is_implicated_in) | |
| Disease | immature platelet fraction | 3.35e-03 | 114 | 158 | 4 | EFO_0009187 | |
| Disease | Drug habituation | 3.45e-03 | 115 | 158 | 4 | C0013170 | |
| Disease | Drug abuse | 3.45e-03 | 115 | 158 | 4 | C0013146 | |
| Disease | Prescription Drug Abuse | 3.45e-03 | 115 | 158 | 4 | C4316881 | |
| Disease | Substance-Related Disorders | 3.45e-03 | 115 | 158 | 4 | C0236969 | |
| Disease | Drug Use Disorders | 3.45e-03 | 115 | 158 | 4 | C0013222 | |
| Disease | Drug Dependence | 3.45e-03 | 115 | 158 | 4 | C1510472 | |
| Disease | Substance Dependence | 3.45e-03 | 115 | 158 | 4 | C0038580 | |
| Disease | Substance Use Disorders | 3.45e-03 | 115 | 158 | 4 | C0038586 | |
| Disease | Organic Mental Disorders, Substance-Induced | 3.45e-03 | 115 | 158 | 4 | C0029231 | |
| Disease | complex trait | 3.49e-03 | 271 | 158 | 6 | EFO_0010578 | |
| Disease | Substance abuse problem | 3.56e-03 | 116 | 158 | 4 | C0740858 | |
| Disease | Eye Abnormalities | 3.68e-03 | 17 | 158 | 2 | C0015393 | |
| Disease | level of Sphingomyelin (d32:1) in blood serum | 3.68e-03 | 17 | 158 | 2 | OBA_2045173 | |
| Disease | immature platelet measurement | 3.90e-03 | 119 | 158 | 4 | EFO_0803541 | |
| Disease | psoriasis vulgaris | 4.32e-03 | 61 | 158 | 3 | EFO_1001494 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 4.32e-03 | 61 | 158 | 3 | EFO_0008317, EFO_0008596, EFO_0020946 | |
| Disease | basophil count | 4.63e-03 | 483 | 158 | 8 | EFO_0005090 | |
| Disease | level of Phosphatidylcholine (16:0_18:2) in blood serum | 5.08e-03 | 20 | 158 | 2 | OBA_2045071 | |
| Disease | word reading | 5.16e-03 | 65 | 158 | 3 | EFO_0005300 | |
| Disease | Tinnitus | 5.33e-03 | 130 | 158 | 4 | HP_0000360 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EDAELIFVGVEHVNE | 26 | Q86YH2 | |
| AVVDLHADDSRISED | 886 | Q9UKV3 | |
| DEDTETRDLQVHGLV | 746 | Q60I27 | |
| EVILAEDETDGEQRH | 401 | O00555 | |
| LAELARVVSAEEEAH | 211 | Q17RC7 | |
| IVHRLKDEETNEDSG | 501 | Q96RT1 | |
| HIVEVTEDGVEDLNE | 401 | O95936 | |
| VITGDADIDHDQVLV | 821 | P11171 | |
| ARHEASAQIDEIVGE | 2546 | Q9NR48 | |
| IDTLHESEEGAEVLI | 171 | Q8WYA6 | |
| ATEEAERIGVDHVAR | 191 | Q7L5N1 | |
| EEEEAAVLHKGDLRA | 2151 | Q68DQ2 | |
| IEHNEARDDVERFVG | 71 | Q9NWD9 | |
| IADLGLAVRHDAVTD | 351 | P36896 | |
| RVDGRSEEEEETPLH | 206 | Q8WXI3 | |
| EGHVLSRPEELEAEA | 221 | Q14195 | |
| TEVEGLADLIHAETE | 156 | Q969Y2 | |
| DAVHDDELTIRVGEI | 11 | Q9Y5K6 | |
| DLTGIEEEEERAQEH | 471 | Q9NQ90 | |
| DVAILAQEIHDVAGD | 1336 | Q9Y4F5 | |
| VDEVGVEDVELVSLH | 116 | Q8N1I8 | |
| AEAEEEIQALTAHRD | 916 | O14578 | |
| DHGELVVRIASLEVE | 76 | P29692 | |
| RDFVDHVDTVEPIDG | 21 | P36575 | |
| TIEDHVIAGNVEEFR | 66 | Q96DT6 | |
| ECLEVETTDVTGHER | 146 | Q7Z5L2 | |
| DEHVLEELETEGERQ | 11 | Q96IZ5 | |
| EDIINVRTAADHVEE | 686 | Q15276 | |
| VDEEQDVERHFSLGE | 646 | Q92698 | |
| RAEKEDTAELGVHLV | 1231 | O95153 | |
| GEFNARAREVELEHE | 531 | Q86YS3 | |
| EAEASLEHEEGKILR | 1546 | P12883 | |
| EIGADIEDRHIVVSC | 81 | P32322 | |
| VSAHDEDARRDGEIR | 1056 | Q14517 | |
| TGAHAEVFVDIIVDD | 2261 | Q14517 | |
| ARSEHEVSEIIDGLS | 366 | Q9Y618 | |
| EEEAVVTEDRDAALG | 71 | Q96EL1 | |
| GAIDDVDIDLHIDVS | 176 | Q8N3A8 | |
| DVVEDISHLLADVAR | 111 | Q92619 | |
| VDLRDESVAHGRIDN | 31 | Q969L4 | |
| RTEKATEGAIHAVEE | 16 | B3EWG6 | |
| VDEFDETIHLERGEN | 591 | Q68CZ1 | |
| KEALDIHAVDGTTEE | 671 | Q8IWI9 | |
| EGHVLSRPEEVEAEA | 221 | Q16555 | |
| HEAVLAALFGEEVLE | 606 | Q9H8L6 | |
| HAAVREDEEDEDLGR | 1171 | Q9Y219 | |
| EEVHDKVVARDLVGA | 746 | Q76MJ5 | |
| ETELTVAVFDHDLVG | 1311 | A9Z1Z3 | |
| VAVFDHDLVGSDDLI | 1316 | A9Z1Z3 | |
| SDDLIGETHIDLENR | 1326 | A9Z1Z3 | |
| EHSETIIELSEERDG | 206 | Q3V6T2 | |
| TVAEGLIEDHFDVTV | 226 | Q9NZ08 | |
| RTEKATEGAIHAVEE | 16 | B3EWG3 | |
| RVTGEADVEFATHED | 326 | P55795 | |
| ELEEAALRHEATVAA | 1226 | A7E2Y1 | |
| RLDALVAEEHLTVDA | 181 | Q9UKK9 | |
| EHGVFEITLETVDRA | 1491 | Q5H8C1 | |
| LERDECAEHIEGERA | 236 | H3BV12 | |
| VDLGDHREVLSFDVT | 421 | Q86TG7 | |
| DEGDADEVTKQRIHD | 1591 | Q7LBC6 | |
| VEAAETIKEETDGLH | 2171 | O94854 | |
| TSADEIHEGDLVEVV | 126 | O94806 | |
| ATEELRREIGEATEH | 1261 | P55268 | |
| ATVGDLEEIQRAHAE | 1701 | Q96RT7 | |
| LSVEDDTGHRIIIED | 2141 | Q92616 | |
| RVTGEADVEFATHED | 326 | P31943 | |
| QEVIDVLETDGHFRE | 56 | Q02818 | |
| EVLRLLDEDHTGTVE | 56 | Q9UBG3 | |
| EEAALRRALEHTDGD | 511 | Q8TE96 | |
| RGLEDHESVVEVQAA | 156 | Q14451 | |
| VNVHGALEVVDDALE | 291 | Q86VI3 | |
| ERALAALEEHVADEN | 116 | Q5BKU9 | |
| SRTFHEEEGIDEVIV | 131 | Q9Y6X9 | |
| EHVARIAEEKAREAE | 296 | Q9Y6X9 | |
| SIITDDVVDIAGEEH | 261 | O43422 | |
| GSSVVRLVDHPDDEE | 791 | Q6ZMV5 | |
| HIIEDLEDVDVQEGS | 3006 | Q5VST9 | |
| IVRGLVDAEVTADED | 4161 | Q5VST9 | |
| LVEAIERTGLDSESH | 131 | O00459 | |
| EDVVRLVVGHLAEAD | 421 | Q9P2J9 | |
| STQHVVLLREDEVGD | 131 | Q9UFP1 | |
| QGAEELLDEESRIHA | 186 | Q567U6 | |
| LEFKRHVGEEEEDTN | 46 | A0AVF1 | |
| SRAEIEHEALIDGNL | 1461 | Q96N67 | |
| LEVAHTKDAETGEEV | 381 | Q8TD26 | |
| RSELEHSVDLEEALG | 141 | H7BZ55 | |
| HSVDLEEALGRLEAA | 146 | H7BZ55 | |
| QEEEAKSGHLSREVD | 706 | Q4L180 | |
| VERNGLHSVVDDDLD | 561 | Q8IXL6 | |
| AVREALVTHGEDTAD | 86 | P10635 | |
| EESAEKHDIGVARLE | 731 | Q5T1B0 | |
| SRVEEAEGHTEVTEA | 356 | Q96BT3 | |
| EGRDATDQHIVDVAL | 516 | Q14055 | |
| EDDIDVLDVDLGHRE | 811 | Q2V2M9 | |
| ISELLREAVEDQTHG | 371 | Q00597 | |
| DDIKVEHAVELDTGA | 1346 | Q3T8J9 | |
| LDLGFAEQVEDIIHE | 296 | Q9BQ39 | |
| DDGVAVICRVDHESL | 196 | Q8N3J6 | |
| VTDDEGNRLSHEDIR | 306 | Q6ZWL3 | |
| GNRLSHEDIREEVDT | 311 | Q6ZWL3 | |
| ERFHSETLTEGDLVD | 156 | O75828 | |
| DRHSGASAEVQKEEE | 411 | Q99615 | |
| EVTEEFGVHLAELTV | 51 | Q96P70 | |
| VFVEIDLGDHAEEVV | 156 | A0A1B0GUA9 | |
| VLEHEEVRAGAVSAL | 481 | Q9Y678 | |
| SEDIEILEHAGELVI | 756 | Q66K89 | |
| GIEDILERHEEAESD | 1091 | Q9Y4K1 | |
| LERDECAEHIEGERA | 236 | I6L899 | |
| LERDECAEHIEGERA | 236 | A6NCC3 | |
| LAELVALEAREHGDV | 171 | Q6ZMB0 | |
| SQGVVEHEEDEESRR | 96 | Q9Y666 | |
| IQGRELSDEEVEHLS | 826 | Q9BY12 | |
| VGDEEGRRSHECIID | 136 | Q9UBP4 | |
| EKRIVITGDADIDHD | 1036 | Q9Y2J2 | |
| EEEDEDELHIGRTAQ | 871 | Q14114 | |
| SVNGETVHREEEKER | 561 | Q9UPQ0 | |
| GHAEAKLEAEEAIEV | 371 | Q9H814 | |
| EIHVAISAEDIRDDG | 1011 | P78504 | |
| FVGDDDVLNHILDRE | 16 | Q13416 | |
| RTEKATEGAIHAVEE | 16 | B3EWG5 | |
| RVTGEADVEFATHEE | 326 | P52597 | |
| EDFIEHLSEGALAIE | 936 | Q9NQT8 | |
| LDGEDHAAERTVEDV | 76 | Q96EL2 | |
| VDVLADHAGELVRTD | 56 | Q13761 | |
| AREEQEAHTDLKESG | 131 | A6NKG5 | |
| ELHVVGDEDVVLREA | 1221 | A6NKG5 | |
| DGRHAVVEVEDVPLA | 136 | Q5H9L4 | |
| HRGNIAEDTEVDILV | 1361 | O75691 | |
| ETQEEDVVLLTAGEH | 431 | Q6PI48 | |
| RIDVTTDGRHAEVEF | 126 | Q96Q11 | |
| RLHVVEVNEDGTEDT | 336 | Q16650 | |
| EGEEIAREGSHEARV | 66 | Q9Y285 | |
| EEVGARAQEILDESH | 3656 | Q8NF91 | |
| DDDVAAVVDGRLSIH | 296 | Q06210 | |
| DETRDHVEVCPDAGV | 266 | Q7L592 | |
| EGVTRRHVLSDLEDD | 1136 | Q8N4C6 | |
| EGAVDLDHVTDERER | 2306 | Q6ZNJ1 | |
| ERDSLVSGAAHREEE | 576 | O00291 | |
| DDVSEVDARHIIENA | 696 | P51532 | |
| VLSAEQLRDEEVHAG | 96 | P50454 | |
| DEVDSLLCERREGEH | 441 | Q9UBP0 | |
| TIAAEEQLEGEVDHA | 416 | Q6ZRS2 | |
| EEILEVATARGAADE | 56 | Q8NCF5 | |
| HLEDGARTETAEELR | 316 | Q9BWW9 | |
| RNSDHGEDEVIAVSE | 86 | Q14865 | |
| SDLGELDHVVEILVE | 226 | Q9BXL8 | |
| GHCRIEVSREEIFEE | 391 | Q9HAU4 | |
| TEAEIDAHLVALAER | 231 | P60900 | |
| LVVVRSKTEDHEEAG | 296 | Q9BXS4 | |
| ELAAHEVSASEAEER | 396 | Q5TAP6 | |
| GIEDVLLHDFLEDVS | 231 | Q6ZV50 | |
| GARVHALTVEEEDDS | 306 | Q5VZP5 | |
| IVTSEELGQDLEHVE | 171 | Q13813 | |
| ADVAVVALSHEELIG | 706 | O15067 | |
| NEVTAHELGEEAVLL | 136 | Q92670 | |
| EDVSADVEERFHLGL | 881 | Q8TEQ6 | |
| HLEEARVVAVSDGET | 721 | Q8IZH2 | |
| DADGLVIDQHEIFVD | 111 | Q16560 | |
| AGEHAEAIASREQEV | 1906 | Q9H254 | |
| QGHTTVDELARREDV | 2811 | Q15149 | |
| EEVHVEGSSDSVVLE | 1041 | Q8IUG5 | |
| LAEIFRASGEHVTDE | 116 | P02585 | |
| RASGEHVTDEEIESL | 121 | P02585 | |
| IEETHLVVLEDDEGA | 291 | Q5T4F4 | |
| SGEEAVAVVEDFQRH | 121 | Q9P0L1 | |
| QDGEELSRTLHLEEV | 1816 | Q9UL36 | |
| LHQIVVDRVEAEDGT | 436 | Q9NS98 | |
| GDVRRTDEVAIHQES | 891 | Q9WJR5 | |
| IEAEVENVFHSLDGE | 966 | Q9C0G0 | |
| DTGVRVELAEEDHGR | 456 | Q9Y3S1 | |
| VELAEEDHGRKSTIA | 461 | Q9Y3S1 | |
| GESIIRCDEDEAHLA | 121 | P36406 | |
| GDTEIHRVEPEDVAN | 416 | Q9UHV5 | |
| ELAKEHGITDDDLRV | 361 | Q5TAX3 | |
| DRHGEEVTPEDVLSA | 996 | P11498 | |
| AGVTHLEESDIIDLE | 186 | Q8NFA0 | |
| EAKLEGEHERDLEST | 1391 | Q5T200 | |
| SAAEEHLEVLREAAL | 191 | Q9Y2Y6 | |
| LERDECAEHIEGERA | 236 | F8WBI6 | |
| AREAAEEAEREHQEA | 631 | Q96M32 |